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Prologue 
 
“The tragedy of life is not that it ends so soon, but that we wait so long to 
begin it.” 
 
W.M. Lewis (1878 – 1945) 
 
This thesis explores depression in palliative care. However, my interest in 
this complex subject was not triggered by depression in palliative care 
patients, but by the opposite: the absence of mood symptoms in the face of 
dying. As many health caregivers do, I perceived mood symptoms as quite 
imaginable when people live in the face of death. I found the absence of 
mood symptoms more surprising than their presence. Working as a doctor 
in general practice, in a nursing home and in a hospice, I attended palliative 
care patients who showed symptoms, signs and behaviors congruent with 
depression. However, frequently, I also met patients who seemed at ease 
with their situation and did not show any sign of depression. These 
observations left me questioning the most. 
I think of Mr. G., a cachectic 59-year-old man with prostatic cancer who 
fiercely denied the fact that he was dying and was still rapidly adapting to 
the disabilities caused by his illness. He seemed to be enjoying every day of 
his life. 
Or Mr. H., a 48-year-old man with three children aged 18, 16 and 8, who had 
a history of depression. When I first met him, he suffered from incurable 
metastatic bowel cancer, but he seemed to be living his life in a balanced 
way, actively and purposefully, without any sign of depression. 
Depression in palliative care: Normal sadness or disorder? 
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Mrs. V., a woman in her seventies with uterus cancer, enjoyed the company 
of her family and church members who visited her frequently and made 
jokes about life and death. 
These patients, however different in their acceptance and their coping with 
terminal illness, did not show signs of depression. They were expressing a 
continuous vitality that seemed adaptive to their situation, even in the 
perspective of dying. It left me wondering about what their ‘secret’ was and 
if I was missing something essential. I questioned what depression actually 
means in the context of palliative care. The results of my questioning are 
published in this thesis. 
I hope that this thesis can help us as health caregivers to attune ourselves to 
the specific context of the palliative care patient and deliver integral, holistic 
palliative care. The exploration that has lead to this thesis has already 
contributed to a better personal integration of living and dying in my own 
life. In her book ‘Intimate Death’ Marie de Hennezel posed that the dying 
teach us how to live. I can confirm this statement from my own experiences 
in the many interviews with palliative care patients that I was allowed to do. 
I am most grateful that I have been given the opportunity to be taught in 
this way. 
 
 11 
 
Chapter 1 
Introduction 
1.1  Palliative care 
A minority of people die an acute cause of death, the main causes of death 
in the Netherlands being cancer, cardiovascular disease and respiratory 
disease1. This implies that for most people a short or longer period of 
disease precedes actual death. A terminal illness can be a highly stressful 
situation that does not only threaten a patient’s life but also the quality of 
the remaining lifetime. This is the context in which palliative care is 
delivered. According to the World Health Organization (WHO), palliative 
care affirms life while regarding dying as a normal process. The WHO defines 
palliative care as ‘an approach that improves the quality of life of patients 
and their families facing the problems associated with life-threatening 
illness, through the prevention and relief of suffering by means of early 
identification and impeccable assessment and treatment of pain and other 
problems, physical, psychosocial and spiritual’.2 It is known that palliative 
care patients experience multiple problems. A study of Osse et al. reports 
that, on average, palliative care patients experience 37 different problems 
and require more professional attention than they were currently given for 
eight problems. The five most prevalent problems reported were: fatigue, 
heavy housework, coping with the unpredictability of the future, fear of 
metastasis and frustrations because of restrictions in their daily activities3. 
The context of palliative care is a very specific context: it comprises many 
physical, psychological, social and spiritual challenges that have a complex 
interrelatedness. Feelings of sadness and depression can be part of a 
patient’s experience, and when this occurs, it will have an impact on the 
patient’s wellbeing. However, sometimes to our surprise, it is not self-
evident that palliative care patients experience depressive symptoms or 
depression. This thesis is directed at depressive symptoms and depression in 
the palliative care trajectory. Deze tekst dient slechts als opvulling.
Depression in palliative care: Normal sadness or disorder? 
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1.2 Depression in palliative care 
1.2.1 What is depression? 
 
“A grief without a pang, void, dark, and drear, 
A stifled, drowsy, unimpassioned grief 
Which finds no natural outlet, no relief 
In word, or sigh, or tear” 
 
Samuel Coleridge (1772-1834)4 
 
Coleridge poetically describes the phenomenon of depression. In doing so, 
he provides us with a description of the inner feeling of the person suffering 
from depression and also refers to the unnaturalness in this feeling and the 
absence of finding relief in certain behavior (word, sigh, tear) that would 
normally be expected to give some relief. 
In health care, in the clinical definition of depression, the unnaturalness and 
maladaptive qualities of depression are reflected in the term ‘disorder’. The 
most widely used clinical definition of depression is the descriptive 
definition of the DSM-IV for major depressive disorder or major depression5. 
This description, that has also been incorporated in Dutch national 
guidelines for depression6,7, states that a depressive disorder should be 
diagnosed if five of the following symptoms occur almost daily during at 
least two weeks: depressed mood, decrease of interest, weight loss, 
insomnia or hypersomnia, psychomotor agitation or retardation, fatigue or 
loss of energy, feelings of worthlessness or excessive guilt, diminished ability 
to think or concentrate or indecisiveness or recurrent thoughts of death or 
Chapter 1 
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suicidal thoughts. At least one of the symptoms should be depressed mood 
or decrease of interest. 
The term ‘depression’ is often used in clinical practice, sometimes referring 
to the DSM-IV definition of depressive disorder, but sometimes also 
referring to feelings of a patient, depressive symptoms or a depression score 
on a screening instrument. ‘Depression’ is an ambiguous term that in itself 
does not clarify from which perspective (e.g. feeling of the patient, clinical 
diagnosis by a psychiatrist) the concept is approached. Whenever the use of 
the term ‘depression’ is not specified, it makes it difficult to interpret 
findings. Sometimes, both in clinical practice and clinical research, other 
terms are used such as mood symptoms, sadness, despair, hopelessness and 
distress, all referring in slightly distinct ways to (aspects of) depression or 
symptoms related to depression. 
Despite the apparent clarity that the DSM-IV definition of depressive 
disorder brings, the application of this definition in clinical practice can still 
be unclear. All DSM-IV definitions of disorders specify that a disorder must 
involve a dysfunction within the individual and must not be an expectable 
response to a stressor5. The person applying the DSM-IV definition thus has 
to (subjectively) appraise both the extent of dysfunction in the patient and 
what would be an expected response to the stressor. Consequently the 
application of the definition may depend partly on the assessor’s attitude 
and beliefs about normality and/or on the individual context of the patient. 
Both the validity and the utility of the concept of depressive disorder are 
subject to dispute, because depressive disorder overlaps with many other 
physical and mental diagnoses and furthermore cannot be dissociated from 
social and cultural elements8,9. 
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Table 1. Frequently used terminology for depression 
Depression  Oxford 
Dictionary of 
English, 2009 
Severe, typically prolonged feelings of despondency and 
dejection or a mental condition characterized by severe 
feelings of hopelessness and inadequacy typically 
accompanied by a lack of energy and interest in life. 
(Clinical) 
Depression  
Online: 
Dictionary.com 
Depression: a condition of general emotional dejection 
and withdrawal; sadness greater and more prolonged 
than that warranted by any objective reason. 
Clinical Depression: a depression so severe as to be 
considered abnormal, either because of no obvious 
environmental causes, or because the reaction to 
unfortunate life circumstances is more intense or 
prolonged than would generally be expected. 
Depression  Wikipedia Depression: A state of low mood and aversion to activity. 
Certain mood disorders, such as major depressive 
disorder and dysthymia that feature depressed mood are 
commonly referred to as simply depression. 
Clinical depression or Major Depressive Disorder: A 
mental disorder characterized by episodes of all-
encompassing low mood accompanied by low self-
esteem and loss of interest or pleasure in normally 
enjoyable activities. This cluster of symptoms (syndrome) 
was named, described and classified as one of the mood 
disorders in the 1980 edition of the American Psychiatric 
Association’s diagnostic manual.  
The term "depression" is ambiguous. It is often used to 
denote this syndrome but may refer to other mood 
disorders or to lower mood states lacking clinical 
significance. 
Depression  World Health 
Organization 
A mental disorder that presents with depressed mood, 
loss of interest or pleasure, feelings of guilt or low self-
worth, disturbed sleep or appetite, low energy, and poor 
concentration. 
Chapter 1 
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Depressive 
disorder, 
DSM-IV-TR 
 Five or more of the following symptoms have been 
present during the same 2-week period and represent a 
change from previous functioning. 
- depressed mood most of the day* 
- markedly diminished interest or pleasure in all, 
or almost all, activities most of the day* 
- weight loss or gain or decrease or increase in 
appetite 
- insomnia or hypersomnia 
- psychomotor agitation or retardation 
- fatigue or loss of energy 
- feelings of worthlessness or excessive or 
inappropriate guilt 
- diminished ability to think or concentrate, or 
indecisiveness 
- recurrent thoughts of death, or suicidal ideation 
or planning or a suicide attempt 
One of the symptoms marked with * must be present. 
Depressive 
symptoms 
 Main symptoms: low mood, lack of interest or pleasure 
Other symptoms: Change in weight or appetite, insomnia 
or hypersomnia, agitation or passivity, fatigue or loss of 
energy, feelings of worthlessness or inappropriate guilt, 
diminished ability to think or concentrate or 
indecisiveness, recurrent thoughts of death or dying or 
suicidal ideation or a suicide attempt. 
Endicott criteria: psychological depressive symptoms 
used to replace the somatic symptoms in cancer patients: 
 Tearfulness, depressed appearance 
 Social withdrawal, decreased talkativeness 
 Brooding, self-pity, pessimism 
 Lack of reactivity, blunting 
Depressive 
complaints 
 Subjective description of patients burden related to 
depressive symptoms. 
Depression in palliative care: Normal sadness or disorder? 
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In this thesis we will use the term depression, referring to the definition 
given by the World Health Organization (WHO) which states that depression 
is a mental disorder that presents with depressed mood, loss of interest or 
pleasure, feelings of guilt or low self-worth, disturbed sleep or appetite, low 
energy, and poor concentration. We will use the term depressive disorder 
when the condition explicitly fulfills the descriptive criteria of the DSM-IV as 
applied by clinicians. 
Worldwide, depression is the leading cause of disability as measured by 
YLDs (years lived with disability) and the fourth leading contributor to global 
burden of disease as measured by DALYs (disability adjusted life years)10. 
The World Health Organization (WHO) estimates that depression will be the 
second highest ranked cause of disease burden in developed countries by 
the year 202011. In the Dutch general population the lifetime prevalence of 
depressive disorder is reported 18.7%12. 
Research shows that there is a large co-morbidity of depression with other 
mental health disorders, such as anxiety or substance abuse13-15, and also 
with medical conditions, such as cardiovascular disease, diabetes mellitus, 
chronic obstructive pulmonary disease or cancer16-18. In the case of 
comorbidity, the relationship between depression and the comorbid disease 
can be bidirectional, which makes the assessment of depression more 
complex. 
The reported prevalence of depression in palliative care patients varies 
substantially from 1% to 69%19, presumably depending on using different 
definitions of depression and various ways of diagnosing, using different 
screening or assessment tools. A review on assessment methods for 
depression in palliative care patients showed that few studies classify 
depression by referring to a diagnostic system20, which makes it difficult to 
report on the exact prevalence of depression in palliative care patients. 
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1.2.2 Normal sadness or depression? 
In the context of palliative care it seems obvious that sadness is quite 
common and can, to a certain extent, be considered normal and even 
adaptive in the palliative care situation. It is also shown, however, that 
depression in a palliative care context can greatly affect the quality of life of 
both patients and caregivers21,22: depression imposes a burden and is 
associated with lower quality of life, increased disability, poorer prognosis, 
higher mortality, longer inpatient episodes and elevated health care costs. 
Furthermore, depression is associated with poor treatment adherence and 
increased difficulties of palliation of physical symptoms such as pain23-27. 
More generally, it can codetermine a suboptimal outcome in the last phase 
of life in hampering patients to successfully accomplish the tasks that may 
arise in this phase such as saying goodbye, reflecting on their life and 
dealing with unfinished business. However, labeling ‘normal sadness’ as 
depression has disadvantages for patient and society as well: medicalization 
of normal feelings and behavior, adverse side events and unnecessary 
interactions from medication, unnecessary and intensive treatments and 
higher health care costs. Therefore, while active case finding of depression 
in palliative care patients can be of great importance, it can only be 
successful when one is able to distinguish between ‘normal sadness’ and 
depression.  
There are several difficulties in the process of diagnosing depression in 
palliative care patients. Firstly, some symptoms that can be present in a 
palliative care patient, such as weight loss or fatigue, can originate from 
both the physical disease or from depression19. While physical symptoms 
and depressive symptoms can share a common pathway of distress, physical 
symptoms may increase a depressed feeling whereas a depressed feeling 
can also result in more physical suffering. Secondly, it can be difficult to 
distinguish grief from depression in palliative care patients. Grief and 
depression can present similarly in palliative care patients28. Bereavement in 
a palliative care patient is an important functional process that can be 
facilitated with psychosocial support and counseling and may be hampered 
Depression in palliative care: Normal sadness or disorder? 
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by pharmacological treatment that is often given in the case of a 
depression29. Thirdly, attending to emotional issues may be difficult for both 
patients and physicians. In advanced cancer patients only in a minority of 
consultations with their doctor, emotional issues were explicitly 
discussed30,31. Finally, as stated before, the DSM-IV definition of depressive 
disorder specifies that to diagnose a depressive disorder, the ‘dysfunction’ 
that is observed must not be an expectable response to a stressor. This part 
of the assessment is especially challenging in a palliative care context. In 
facing death it seems particularly difficult to define what an expectable 
response to this stressor is. This may be dependent on many individual 
factors in both the palliative care patient and the professional caregiver who 
is making the assessment. 
1.2.3 Screening instruments for depression in palliative care 
Active screening for depression in palliative care patients is advocated32. 
Screening instruments could facilitate the assessment of depression in 
palliative care patients33. However, the unclear and ambiguous way of using 
the concept of depression in palliative care is reflected in the use of many 
different assessment and screening tools. A review showed that 106 
different assessment methods are used for depression in palliative care and 
that there is no consensus on which screening instrument to use in the 
palliative care context20. In clinical palliative practice more than half of the 
palliative care physicians do not routinely use screening tools for 
depression34. Screening for depression in palliative care can be received with 
apprehension – in particular because of the problems to distinguish normal 
sadness from depressive disorder in the context of a palliative trajectory. 
Screening instruments for depression used in palliative care should be able 
to identify patients who would benefit from an intervention in this specific 
context. 
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1.3 Research objectives and outline of this thesis 
The aim of this thesis was to study depression in palliative care from 
different perspectives. We aimed to answer the following questions: 
1. What is the prevalence of depression in palliative care patients? 
2. What is the validity of the Beck Depression Inventory (BDI-II) as a 
screening instrument for depressive disorder in palliative care 
patients? 
3. How is depressive symptom burden, as measured by the Beck 
Depression Inventory (BDI-II), Beck Depression Inventory Primary 
Care (BDI-PC) and the Hospital Anxiety and Depression Scale (HADS), 
related to physical symptom burden in palliative care patients? 
4. What resources and ways of coping do palliative care patients 
experience that help them prevent or manage mood symptoms in 
facing terminal illness? 
5. How do family physicians diagnose and manage depression in 
palliative care? 
In chapter 2 and 3 of this thesis we report on the prevalence of depression 
in palliative care patients. We studied the prevalence from the perspective 
of the general practitioner by reporting the prevalence of depressive 
disorder in the last phase of life using the Continuous Morbidity Registration 
(CMR) (Chapter 2). Secondly, we studied the prevalence by performing a 
psychiatric interview in a sample of palliative care patients (Chapter 3). 
Chapter 4 and 5 report the use of screening instruments for depression in 
palliative care patients. We studied the validity of the Beck Depression 
Inventory (BDI-II, appendix 1) in screening for depressive disorder in 
palliative care patients (Chapter 4) and the relation between scores on 
screening instruments for depression (BDI-II, Beck Depression Inventory 
Primary Care (BDI-PC) and Hospital Anxiety and Depression Scale (HADS, 
appendix 2)) and physical symptom burden (Chapter 5). In chapter 6 we 
Depression in palliative care: Normal sadness or disorder? 
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report the findings of an exploration of the perspective of the patient on 
what helps to prevent or address mood symptoms in a palliative care 
context. In chapter 7 results of a focus group study on the perspectives of 
family physicians on diagnosis and management of depression in palliative 
care patients are reported. Finally, in the general discussion and conclusions, 
we summarize our findings and place our findings in the context of current 
knowledge and development in health care and give suggestions for future 
research (Chapter 8). This thesis will end with an Epilogue in which I reflect 
on some personal observations that I have found valuable. 
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Abstract 
Purpose: Depression is assumed to be common in chronic patients during 
their last phase of life and is associated with poorer outcomes. The 
prevalence of depression is widely varying in previous studies due to the use 
of different terminology, classification and assessment methods. This study 
explores the reported incidence of depressive disorder, as registered in the 
last phase of life of patients who died from cardiovascular disease, cancer or 
COPD, in a sample of primary care patients. 
Methods: A historic cohort study, using a 20-year period registration 
database of medical records in four Dutch general practices (a dynamic 
population based on the Continuous Morbidity Registration database) was 
performed to explore the prevalence of depressive disorder in all patients 
who died from cardiovascular disease, cancer or COPD. 
Results: In total 982 patients were included. Nineteen patients (1.9%) were 
diagnosed with a new depressive disorder in the last year of their life. The 
lifetime prevalence of depressive disorder in this sample was 8.2%. 
Conclusions: The incidence of depressive disorder in the last phase of life is 
remarkably low in this study. These data were derived from actual patient 
care in general practice. Psychiatric diagnoses were made by general 
practitioners in the context of both patient needs and delivered care. We 
recommend a broader concept of depression in general practice to improve 
the diagnosis and treatment of mood disorders in patients in the last phase 
of life. 
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Introduction 
Depression is common in patients during their last phase of life, and often 
encountered during a palliative trajectory1. Different terminology, 
classification and assessment methods for depression, depressive symptoms 
and depressive disorder in palliative care studies are used, resulting in a 
wide range of reported prevalence of depression between 3 and 77 % of 
patients1-3.  In advanced cancer patients, the prevalence of a depressive 
disorder as assessed by a structured psychiatric interview is reported to be 
8.7 – 11.8 %, depending on the time after diagnosis4. Patients with 
depression have a poor treatment adherence, increased difficulties in 
palliation of physical symptoms, increased disability, poorer prognosis, 
longer inpatient episodes and elevated health care costs5-8. Effective 
interventions for depression like psychotherapy or medication are available 
for patients in a palliative trajectory5,9-12. Given the negative impact of 
depression in the palliative trajectory, recognition, correct diagnosis and 
treatment of depressive disorder is of the utmost importance.  
General practitioners (GPs) have an important role in supporting and 
treating patients in a palliative trajectory13-15. Hence, GPs also have a major 
role in recognizing depression in patients in the last phase of their life. In 
primary care, patients who are diagnosed with a depressive disorder by GPs 
seem to meet diagnostic criteria of depression using standardized 
psychiatric CIDI and SCAN interviews16. However, other studies show that 
depressive disorders might be under-recognized and under-treated by GPs17-
19. It is unclear to what extent depressive disorders are under-diagnosed in 
patients during their last phase of life.  The EAPC calls for proactive 
screening and treatment of depression in patients with terminal cancer with 
a limited survival time1. Therefore, it is important to know the prevalence of 
depressive disorder during regular (primary) care of patients in their end 
stage of life.  
This study explores the reported incidence of depressive disorders, as 
registered in the last year of life of a population of patients who died from 
cardiovascular disease, cancer or COPD, in primary care practices of the 
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region of Nijmegen using a 20-year period registration database of medical 
records of general practitioners. 
 
Methods 
This study is a historic cohort study with a dynamic population based on the 
Continuous Morbidity Registration (CMR) database that has a 45-year 
observation period. According to the law and policy in the Netherlands, 
ethical approval is not required in case of research of anonymous morbidity 
or mortality registration. Patients whose information is registered in the 
CMR have signed an informed consent form to agree that this information 
can be used anonymously for research purposes. 
The Continuous Morbidity Registration database 
Details of the CMR database have been described elsewhere20. Briefly, since 
1967 the CMR registers all new episodes of morbidity, presented to the GPs 
in four general practices in the surroundings of Nijmegen, the Netherlands. 
The practices have a stable practice population of approximately 12,000 – 
13,500 individuals21. The practice population is representative of the Dutch 
population in terms of age, gender and morbidity patterns22,23. In the 
Netherlands, all inhabitants are listed within a general practice and receive 
their medical care through this particular general practice24. Consequently, 
these general practices have a very complete overview of their patients’ 
medical history. 
To classify morbidity the Dutch translation of the Royal College of General 
Practitioners’ E-list was introduced in 1967– at that time this was the only 
general practice classification available. The E-list is based on the ICD-7 and 
has been updated in 1984 to make the list compatible with the ICHPPC-225. 
The E-list classification has been maintained in the CMR-database ever since, 
to preserve consistency of data over time. Morbidity is prospectively 
registered by the GP at the time of diagnosis with a diagnosis-oriented 
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classification in the individual medical life history of the consulting patient. 
In addition, cause of death is recorded and entered in the system. 
Medical diagnoses made after referral to other specialists are also included 
in the CMR database. When disease progression, outcome of additional 
testing or specialist review after referral changes the diagnostic perspective, 
the recorded diagnosis is revised and the correct diagnosis will thus have the 
time stamp of the first patient encounter for this disease. When corrections 
occur, only the corrected diagnosis is available in the database. 
Furthermore, in the database, for each patient, socio-demographic 
information (age, sex, and socio-economic status classified as low, middle, 
and high) and data on morbidity and mortality – if applicable - are available. 
Registration of depressive disorder in the Continuous Morbidity Registration 
The Dutch national guidelines for depression used in general practice are 
consistent with international guidelines and state that a depressive disorder 
should be diagnosed if five of the following symptoms occur almost daily 
during at least two weeks: depressed mood, decrease of interest, weight 
loss, insomnia or hypersomnia, psychomotor agitation or retardation, 
fatigue or loss of energy, feelings of worthlessness or excessive guilt, 
diminished ability to think or concentrate or indecisiveness or recurrent 
thoughts of death or suicidal thoughts. At least one of the symptoms should 
be depressed mood or decrease of interest26. 
This definition that was first explicitly introduced in the guideline in 1994 
reflects the diagnostic criteria that had been used in the CMR before. 
In this study the medical history of deceased patients was analyzed for 
episodes of depressive disorder. It has been demonstrated that for the large 
majority of patients in the CMR database their diagnosis is in agreement 
with the above-mentioned diagnostic criteria for depression16,27. 
Selection of patients 
In this study, we recruited all patients in the CMR database who died of 
cardiovascular disease, COPD or cancer and who matched the following 
inclusion criteria: (i) patients had died in the period from 1 January 1989 to 1 
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January 2009 of cardiovascular disease, COPD or cancer and (ii) patients had 
been listed with the practice for five or more years before their death. 
Three groups of ‘causes of death’ were formed: cardiovascular disease, 
cancer and COPD. In the three groups, we included different diseases. In the 
group of patients who died from cardiovascular disease  ‘death by 
cardiovascular disease’ , we included all patients who were registered with a 
cause of death of myocardial infarct, heart failure, atrial fibrillation, 
cerebrovascular accident, cardiac valve disease. Furthermore, patients who 
had a history of at least one of these diagnoses and had a registered cause 
of death of cardiac arrhythmia, tachycardia, peripheral arterial disease, 
pulmonary embolism, angina pectoris, other heart disease, other vascular 
disease, other diseases of the cardiovascular system, were also included in 
the group ‘death by cardiovascular disease’. In the group of patients who 
died from cancer  ‘death by cancer’ , we included all patients who were 
registered with a cause of death of any carcinoma, melanoma, leukemia, 
multiple myeloma or lymphomata or unknown metastasis. In the group of 
patients who died from C PD  ‘death by C PD’ , all patients who had a 
registered cause of death of obstructive and/or chronic bronchitis or 
bronchiectasis were included. Furthermore patients who had a history of 
obstructive or chronic bronchitis or bronchiectasis and had a registered 
cause of death of pneumonia or other lower airway disease were also 
included in the group ‘death by C PD’. 
Statistical analysis 
Descriptive statistics were used to summarize the characteristics of the 
patient sample. The medical history of the included patients was analyzed 
for the diagnosis of a new episode of depressive disorder and descriptive 
statistics were used. The date of a new episode of depressive disorder was 
related to the date of patient’s first diagnosis of COPD, cardiovascular 
disease or cancer and to the date of their death. 
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Results 
Population characteristics 
From 1 January 1989 to 1 January 2009, 1666 deaths were recorded in the 
CMR database. 200 cases were excluded because patients were registered 
less than five years in the practice and thus did not meet inclusion criteria. 
Of the 1466 deaths 462 patients (31.5%) died of causes other than 
cardiovascular disease, cancer or COPD. Twenty-two patients were excluded 
because no diagnosis matching the cause of death was registered, so the 
order of occurrence of morbidity could not be determined. Of the remaining 
sample of 982 patients, 506 patients (51.5%) died of cardiovascular disease, 
414 patients (42.2%) died of cancer and 62 patients (6.3%) died of COPD.  
Incidence of depression in the last 6 and 12 months before death 
Of the 982 included patients, nineteen patients (1.9%) were diagnosed with 
a new episode of depressive disorder in the last year before their death. Of 
these nineteen patients, eleven patients (1.1%) were diagnosed with a 
depressive disorder in the period of six months before their death. 
The lifetime prevalence of depressive disorder in this sample was 8.2% (81 
patients: 49% male, 51% female). The mean age at the time of death of 
patients with or without a lifetime depression was respectively 72.6 and 
73.6 years. Of the patients who died from cardiovascular disease, cancer or 
COPD, lifetime prevalence of depressive disorder was respectively 6.9%, 
9.9% and 8.1%. 
Of the 81 patients who were diagnosed with an episode of depressive 
disorder, 55 patients were diagnosed with depression before they had been 
diagnosed with the disease (cardiovascular disease, cancer or COPD) that 
finally caused their death, and 26 patients were diagnosed with depressive 
disorder after they received a diagnosis of COPD, cardiovascular disease or 
cancer. 
 
Depression in palliative care: Normal sadness or disorder? 
32 
 
Discussion 
This study offers information about the incidence of depressive disorder in 
the last phase of life derived from actual patient care in primary care and 
reports an incidence of depressive disorder of 1.9% in the last year of life of 
982 patients who died of cardiovascular diseases, cancer or COPD. The 
incidence of depressive disorder in this study does not differ much from the 
1-year-incidence in the general Dutch population of 1.7% that is reported in 
the Nemesis study28.  
Two reviews on depressive disorder in palliative care patients conclude that 
depressive disorder in palliative care patients is common and they express 
concerns about under diagnosis and under treatment2,5. However, the 
conclusion of the first review was that the quality of the evidence was poor 
and that the samples of patients were generally small.5 Although the second 
review has been based on a literature search, no details were provided of 
the review methodology and the influence of study quality on the outcomes. 
So, although the findings of these reviews contrast with the findings of our 
study, we consider the low incidence of depressive disorder in the last year 
of life a valid result from reliable, real life data. The low incidence is in the 
range of the 1-year-incidence in the general population.  
The diagnoses in this study were made in the context of actual patient needs 
and in the context of the delivered care. The long term registration database 
that was used, has maintained a consistent classification system in a stable 
population21. This population is representative for the general Dutch 
population22,23. A comparison of the study sample with the mortality data of 
the general Dutch population in 1990 showed that the study sample is 
representative concerning the proportion of causes of death (cardiovascular 
disease, COPD and cancer) as well as the proportion of male and female 
deaths within the different causes of death29. Furthermore, the classification 
system has been proved to adequately diagnose depressive disorder16.  
A possible explanation for the relatively low incidence of depressive disorder 
in this study may have been that the diagnoses in this study were made in 
the context of delivered care, guided by the patient’s agenda and in the 
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context of patients needs in contrast to population research where 
depression is diagnosed with questionnaires or psychiatric interviews. 
Possibly GPs do not easily classify depressive symptoms in a palliative care 
context as depressive disorder as they consider these – in accordance with 
the patients – as normal reactions in the context of the end of life. Indeed, a 
recent focus group study showed that while GPs are sometimes reluctant to 
classify sadness as depression in a palliative care context, they frequently 
attend to normal sadness in palliative care patients15. GPs can attend to 
emotional issues in a palliative care context without dichotomizing the 
complex pattern of complaints into normal or disorder and with a explicit 
focus on the context of the depressive complaints that the patient 
experiences. 
This study has several limitations. To improve the consistency of our study 
population and the consistency of the patient doctor relationship, we have 
excluded patients who were listed in the practice less than five years. This 
could have resulted in excluding patients with an unstable life, patients who 
left the practice out of dissatisfaction with their doctor or patients who were 
admitted in a nursing home in the last phase of their life. Patients with 
major life events among which moving house may be at a greater risk to 
develop a depressive disorder.  However, in general the CMR registration 
has a stable practice population. Furthermore, if a problem arises in the 
patient-doctor relationship that results in the ending of this relationship, it is 
possible for patients to stay in the same practice with a different general 
practitioner and thus still be part of the CMR database. This makes it 
unlikely that the results have been severely influenced by this bias. 
Furthermore, the inclusion of different diagnoses in the causes of death 
groups can be somewhat arbitrary, especially in the case of death by COPD 
or cardiovascular disease, because some of the diagnoses, such as 
pulmonary embolus, can have a relation with both COPD and cardiovascular 
disease. It is unlikely that this has influenced the results because of the very 
low prevalence of pulmonary embolus. 
Depression in palliative care: Normal sadness or disorder? 
34 
 
Regarding the diagnostic process, we do not know how individual patients in 
this sample were assessed for depressive disorder by their GP. Secondly, 
because different physicians were participating in the CMR there could have 
been inter-doctor variation in assessing depressive disorder. In general, we 
assume this to be small because criteria for diagnosis are discussed in 
monthly meetings, where the application of diagnostic criteria is monitored. 
However, GPs may have a different view or different ways of assessing 
depressive disorder in the last phase of life15 that has not been monitored 
specifically. Furthermore, in interpreting the findings of this study, we must 
take into account that depressive disorder throughout the twenty years of 
data that were included in this study may not have been a stable concept. 
Changes in perspective on depressive disorder, for example the concern for 
medicalization and overtreatment30, may influence the assessment of 
depressive disorder by physicians. In this study, it is unclear what 
perspective on depressive disorder the GPs used over the years. 
This study was too small to compare differences in the incidence of 
depression in the different diagnosis groups. It is likely that people who 
suffer from COPD, cardiovascular disease and cancer experience different 
disease trajectories and it could be that also the incidences of depressive 
disorder are different for the different disease trajectories20. Moreover, 
different cancer types are known to specifically increase the risk for 
depressive disorder, possibly because the cause of specific biological 
characteristics of depressive disorder31-33. Furthermore, in our study we 
aimed to explore the incidence of depressive disorder in the last phase of 
life. However, the patients included in this study suffered from a mix of 
chronic and sub-acute causes of death. It is possible that there are 
differences in incidence of depressive disorder between these groups. 
In this study we have not explored other psychiatric co-morbidity, such as 
anxiety disorders, that can be related to mood symptoms and may also have 
a high incidence in palliative care patients. In a previous study a prevalence 
of anxiety disorders of 7.6% is reported in advanced cancer patients34. 
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In this study we have reported new episodes of depressive disorder in the 
last year of life. Patients who were already diagnosed with depressive 
disorder before their last year of life and continued to suffer from 
depression in their last year of life, were not included in the reported last-
year-incidence. 
 
Previous studies in palliative care patients with cancer report high numbers 
of depressed patients1,2,5. Based on the findings of this study, the 
assumption that the last phase of life is a risk for depression might be 
incorrect. The question remains whether depressive disorder is truly not as 
common in patients in the last phase of life than has been previously 
assumed, or whether this is caused by methodological issues such as 
method of registration and the context of the assessment.  
 
Finally, if the incidence of depressive disorder is low, it does not mean that 
there is no patient need for care for mood symptoms in the last phase of 
life. Patients may benefit from a broader classification of emotional issues, 
in which support can be provided without dichotomizing complaints of 
sadness into normal or depressive disorder. We recommend that the 
context of the patient is explicitly included in this process of diagnosis and 
suggest that patient burden and patient need for support for emotional 
issues should be included in the assessment. 
This seems congruent with the way GPs manage mood symptoms of their 
palliative care patients; they seem to manage these symptoms with a strong 
focus on the context of the patient without needing a diagnosis of a 
disorder15. Therefore, we recommend studying the last phase of life with a 
broader concept of depression to gain more insight in the actual situation in 
clinical practice. 
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“Not everything that can be counted counts, 
And not everything that counts can be counted.” 
 
Albert Einstein (1879 – 1955) 
 41 
 
Chapter 3 
Low prevalence of depressive disorder in 
ambulatory advanced cancer patients using the 
Schedules for Clinical Assessment in 
Neuropsychiatry (SCAN 2.1) 
Published: J Affect Disord. 2012 Feb;136(3):1209-11 
 
 
 
 
 
 
 
 
Franca Warmenhoven 
Eric van Rijswijk 
Chris van Weel 
Judith Prins 
Kris Vissers 
Depression in palliative care: Normal sadness or disorder? 
42 
 
Abstract 
Depressive disorder is assumed to be highly prevalent in advanced cancer 
patients, but the diagnosis of depressive disorder in patients with advanced 
cancer is difficult. The more robust the assessment instrument to diagnose 
depressive disorder is, the lower the reported prevalence of depressive 
disorder in advanced cancer patients. This study confirms a low prevalence 
of depressive disorder (3%) in 64 advanced cancer outpatients using a 
robust structured clinical assessment (SCAN 2.1). Furthermore, in this article 
we discuss possible implications of using predefined psychiatric labeling in 
the assessment of mood symptoms in advanced cancer patients. 
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Introduction 
A terminal illness is a highly stressful situation that does not only threaten 
patients' lives but also their quality of life. Consequently, the prevalence of 
depression is expected to be high in patients in a palliative trajectory. The 
reported prevalence of depression in these patients varies substantially 
from 1% to 69% (Hotopf et al., 2002), possibly depending on the use of 
different screening or assessment tools (Mitchell et al., 2011). This large 
variation marks a dilemma that is paramount in the clinical practice, 
research and education of palliative care. On the one hand it seems obvious 
that depression is common in palliative care and that depression can greatly 
affect the quality of the remaining lifetime of both patients and caregivers: 
It imposes a burden and is associated with lower quality of life (Chochinov et 
al., 2007), increased disability, poor prognosis, higher mortality, longer 
inpatient episodes and elevated health care costs (Irving and Lloyd- 
Williams, 2010; Lloyd-Williams et al., 2008, 2009; Rayner et al., 2009; Reeve 
et al., 2008). Poor treatment adherence, increased difficulties of palliation of 
physical symptoms such as pain codetermine this outcome. 
Yet, on the other hand, feelings of sadness and low mood are quite normal 
responses of people to negative life events. Therefore, active case finding of 
depression in palliative care patients can only be successful when it is able 
to distinguish between ‘physiological’ reactions and symptoms of pathology. 
There is growing concern about overtreatment and medicalization of normal 
sadness (Horwitz and Wakefield, 2007). The issue of diagnosing depression 
in palliative care receives much attention in research. A recent review 
studying assessment methods for depression in palliative care patients 
showed that few studies classify depression by referring to a diagnostic 
system (Wasteson et al., 2009). Active screening for depression in palliative 
care patients is advocated (Rayner et al., 2011), but is received with 
apprehension — in particular from general practitioners because of the 
problems to distinguish normal sadness from depressive disorder in the 
context of a palliative trajectory. A recent meta-analysis showed that the 
prevalence of depression is much lower than previously thought if 
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depression is defined as a depressive disorder assessed in a psychiatric 
interview (Mitchell et al., 2011). In this study we report the prevalence of 
depressive disorder in ambulatory advanced cancer patients as defined by a 
robust structured clinical assessment to diagnose a depressive disorder 
(Schedules for Clinical Assessment in Neuropsychiatry). We discuss possible 
implications of our findings for clinical practice. 
 
Methods 
Patients 
Patients were included in this study when, according to their treating 
physician, they suffered from advanced cancer and had an estimated life 
expectancy between two months and one year. Patients who were unable 
to speak or read the Dutch language or who suffered from cognitive 
dysfunction were excluded. From November 2008 until December 2009, 
patients were recruited from an academic oncology and palliative care 
outpatient clinic and from different family practices that were affiliated with 
the Radboud University Nijmegen Medical Centre. 
Procedure 
After institutional approval of the medical ethical commission, eligible 
patients were asked by their physician if they were willing to participate in a 
questionnaire-interview study on depressive complaints. After patients had 
received information about the study and gave their informed consent by 
mail, a questionnaire was sent to the patient to complete at home. Within 
two weeks after completing this questionnaire, all patients, regardless of 
their score on the questionnaire, underwent a face-to-face diagnostic 
psychiatric assessment interview (SCAN 2.1) for depression by a trained 
interviewer who was blind to the results of the questionnaire. 
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Questionnaire 
The questionnaire that patients completed before the assessment included 
demographic information and a self-report depression scale: the Hospital 
Anxiety and Depression Scale (HADS), a 14-item self-rating instrument for 
anxiety and depression (Bjelland et al., 2002; Zigmond and Snaith, 1983). 
The HADS has been validated in the general population and in cancer 
patients (Mitchell et al., 2010; Mykletun et al., 2001; Vodermaier et al., 
2009). 
Schedules for Clinical Assessment in Neuropsychiatry (SCAN 2.1) 
The face-to face assessment consisted of a psychiatric inter- view (SCAN 2.1) 
by a trained interviewer. The SCAN 2.1 is a semi-structured psychiatric 
interview that has been developed by the World Health Organization. The 
SCAN 2.1 is a validated and reliable instrument to diagnose mood disorders 
(Fink et al., 2004). The computer program that processed the data of the 
interviews generated diagnoses according to the DSM-IV. An interview book 
was used by a trained general practitioner who used the Sections 3, 4, 6, 7 
and 8 that assess stress, depression and anxiety (Giel and Nienhuis, 1992). 
 
Results 
Of 175 patients that were identified as eligible for this study, 86 gave 
informed consent. Of these, twenty patients dropped out because of fast 
deterioration or imminent death. One patient dropped out because she did 
not match the inclusion criteria. One patient dropped out because the 
interview was not performed by a trained interviewer. Eventually, sixty- four 
patients completed the study (37% men, 63% women, age ranged from 45 
to 89 years with a mean of 65 years). All patients suffered from advanced 
cancer. Most frequent were patients with nephroblastoma (17%), 
coloncarcinoma (20%), prostate carcinoma (14%) and breast cancer (11%). 
Within three months, 10 patients (16%) had died and with- in six months 21 
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patients (34%) had died. The mean HADS-T score was 10.0 (SD 7.4), the 
mean HADS-D score was 5.7 (SD 4.2), the mean HADS-A score was 4.6 (SD 
3.8) (Table 1). 
Table 1. Patient scores Hospital Anxiety and Depression Scale 
 Mean (SD) Range 
HADS-T 10.0 (7.4) 0 – 31 
HADS-D 5.7 (4.2) 0 – 19 
HADS-A 4.6 (3.8) 0 – 16  
 
The SCAN 2.1 identified 2 patients (3%) as suffering from a major depressive 
episode. No anxiety disorders were diagnosed in this patient sample. 
 
Discussion 
In this advanced cancer patient sample, only 3% of patients were suffering 
from a depressive disorder as defined by a robust diagnostic instrument 
(SCAN 2.1) for detecting a depressive disorder. Most studies on depression 
in palliative care report higher prevalence of depression in palliative care 
patients (Mitchell et al., 2011). 
The low prevalence found in this study, could be explained by selection bias. 
This study recruited patients with an estimated life expectancy of less than a 
year, whereas other studies use varying definitions of a palliative care 
patient (patients receiving non-curative treatment; patients in hospice 
settings; patients with irresolvable physical complications). Another possible 
selection bias could be that patients who suffer from depression are less 
likely to participate in a study on depression. However, the scores on the 
self-report depression instrument (HADS) vary considerably as indicated by a 
wide range and high standard deviation, pointing to a variety of depressive 
symptom bur- den in this sample. Another reason for the low prevalence 
found in this study could be the fact that the interview was performed by a 
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general practitioner. General practitioners who perform a psychiatric 
interview, in which a clinical assessment is made, might attribute symptoms 
of depression more to the context of the palliative care situation and 
therefore not classify the symptoms as pathological (Warmenhoven et al., 
2012). 
Remarkably, none of the patients in this sample was diagnosed with an 
anxiety disorder. A hypothesis for this could be that the SCAN 2.1 has two 
entry questions for the section anxiety. These questions merely focus on 
anxiety disorders that are either accompanied with vegetative symptoms or 
that are related to a specific situation (fobic disorders). 
Reported prevalence of depression is dependent on the method of 
assessment of depression. Much effort has been put into applying robust 
methods for the assessment of depression. The more robust the method is, 
the lower the prevalence of depression is found (Mitchell et al., 2011). 
Previous studies do not support the common clinical assumption that the 
prevalence of depressive and anxiety disorders increases as death nears. 
However, patients' level of physical distress, acknowledgment of terminal 
illness, and wish to die, possibly reflecting acceptance of dying, increased as 
death approached (Lichtenthal et al., 2009). 
Mood symptoms are influenced by the burden of physical symptoms, social 
issues and spiritual wellbeing (Lo et al., 2010; Rodin et al., 2009). 
Consequently, depression is influenced by these different dimensions, 
especially in the context of a palliative care patient, yet the assessment of 
depression is very often based on the application of a psychiatric 
classification that does not take into account much of the context of the 
patient. From a clinical point of view, it can be more important to find a 
specific method to better identify a patient with a high burden of depressive 
symptoms who would benefit from a specific intervention, than to identify 
patients with a clinical depressive disorder. It might prove necessary to 
focus our attention on patients' needs rather than relying on predefined 
psychiatric labeling. Psychiatric labeling in palliative care patients could be a 
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threat to the internal validity of the multifaceted concept of depression that 
we are aiming for in palliative care patients. We conclude that a psychiatric 
interview may not be the most adequate tool for assessment of depression 
in palliative care patients. Reeve et al. (2008) suggest that clinical practice 
and care of individual patients may be better supported by development of 
a prognostic index considering the predictive power of depressive symptoms 
and risk factors on well-being. We suggest redefining our goal from 
detecting depressive disorder in advanced cancer patients to identifying 
patients with high depressive symptom burden who would benefit from an 
intervention and who have a need for support. 
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"Measure what can be measured, 
and make measurable what cannot be measured." 
 
Galileo Galilei (1564 – 1642) 
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Abstract 
Purpose: Depression is highly prevalent in advanced cancer patients, but the 
diagnosis of depressive disorder in patients with advanced cancer is difficult. 
Screening instruments could facilitate diagnosing depressive disorder in 
patients with advanced cancer. The aim of this study was to determine the 
validity of the Beck Depression Inventory (BDI-II) and a single screening 
question as screening tools for depressive disorder in advanced cancer 
patients. 
Methods: Patients with advanced metastatic disease, visiting the outpatient 
palliative care department, were asked to fill out a self-questionnaire 
containing the Beck Depression Inventory (BDI-II) and a single screening 
question “Are you feeling depressed?” The mood section of the P IME-MD 
was used as a gold standard. 
Results: Sixty-one patients with advanced metastatic disease were eligible to 
be included in the study. Complete data were obtained from 46 patients. 
The area under the curve of the receiver operating characteristics analysis of 
the BDI-II was 0.82. The optimal cut-off point of the BDI-II was 16 with a 
sensitivity of 90% and a specificity of 69%. The single screening question 
showed a sensitivity of 50% and a specificity of 94%. 
Conclusions: The BDI-II seems an adequate screening tool for a depressive 
disorder in advanced cancer patients. The sensitivity of a single screening 
question is poor. 
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Introduction 
Depression seems highly prevalent in patients with advanced cancer. In 
different studies, a large variation of prevalence of depression in advanced 
cancer (4% to 58%) is reported [1]. This large variation in prevalence can be 
explained by the use of different research samples with different risk factors 
like cancer type, age, sex, history of depression, alcohol abuses, and by the 
use of different assessment tools [2–4]. In some patients with advanced 
cancer, a depressive disorder as defined in the DSM-IV can be diagnosed, 
whereas others experience symptoms of depression and low mood but do 
not meet the diagnostic criteria of the DSM-IV. Both situations are 
associated with a lower quality of life and consequently cause a burden for 
the patient and his caregivers [5, 6]. 
In patients with advanced cancer, several factors can influence the 
diagnostic process of depression. Firstly, specific physical signs and 
symptoms presented in a patient with advanced cancer, such as weight loss 
or fatigue, can originate from advanced cancer or from depression [7]. 
Physical symptoms and depressive symptoms may partly share a common 
pathway of distress [8], which makes it difficult to distinguish between cause 
and effect: physical symptoms may increase a depressed feeling on the one 
hand and on the other hand a depressed feeling may result in more physical 
complaints [9, 10]. Secondly, it may be difficult to distinguish grief from 
depression in patients with advanced cancer [11]. Thirdly, for both patient 
and physician emotional issues are difficult to address in this phase of life. 
Only a minority (17%) of advanced cancer patients explicitly express their 
emotional distress to their physician and physicians themselves do not often 
address emotional problems in conversations with advanced cancer 
patients, possibly because they do not feel well trained in communication 
with palliative care patients [12, 13, 17]. 
The recognition of depression is not optimal for oncologists [14, 15] and 
other physicians as well [16] because of the reasons mentioned. If patients 
with advanced cancer who are suffering from a depressive disorder are not 
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identified, they will not be able to benefit from the pharmacological and 
psychological treatments that are considered beneficial [16, 18, 19]. 
Screening instruments could facilitate recognizing depressive disorder in this 
population [20]. Systematic screening for symptoms like depression fits into 
the principles of advanced care planning that is promoted in patients with 
advanced cancer or in need of palliative care [21]. The ideal screening 
instrument combines a high sensitivity with a high specificity. When using a 
cut score in a screening instrument, the optimal cut score for a specific 
patient group can be determined with a receiver operating characteristics 
analysis. The usefulness of a screening tool depends on the positive and 
negative predictive value considering the main aim of the screening. When 
screening for depression in patients in a palliative trajectory, given the 
vulnerability of these patients and the consequences of depression for their 
health status and quality of life, a high negative predictive value seems most 
important. False positive cases can be ruled out in further diagnostic 
assessment. 
Recently, screening for depression with one or two simple questions was 
suggested to be highly specific [22], although different studies report 
different findings on psychometric values of short screening methods [23]. A 
short screening method is appealing because the costs would be 
considerably lower than other methods for diagnosing depressive disorder; 
it is time efficient and many people can be screened for depression in a 
quick and simple way. 
The Beck Depression inventory (BDI-II) is one of the most widely used 
screening tools for depression and it may provide a useful method for 
screening for depression in palliative care [24–26]. This inventory is a self-
report questionnaire that was originally developed to rate the severity of 
depressive symptoms [27]. The BDI-II has shown good psychometric 
qualities as a screening tool for depression. However, the BDI-II contains 
several items on somatic symptoms of depression (for example, questions 
about loss of energy, fatigue, and loss of appetite), which may lead to an 
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overestimation of positive cases in a patient group with somatic illness. The 
BDI-II has been validated in many samples including cancer patients [28]. 
The aim of the present study was to assess the validity of the BDI-II and a 
single screening question as screening tools for depression in Dutch-
speaking patients with advanced cancer. The hypothesis was that both the 
BDI-II and the single screening question are adequate screening tools for 
depressive disorders in Dutch advanced cancer patients. 
 
Methods 
Ethical approval and informed consent 
The study received approval of the medical ethical committee of the 
Radboud University Nijmegen Medical Centre. After obtaining informed 
consent, patients were asked to fill out a self-report questionnaire. Patients 
who were unable to read and understand the Dutch language were 
excluded from participating in this study. 
Sample and design 
From December 2003 until March 2007, all consecutive patients with 
advanced, non-curable stages of metastatic cancer referred to a new 
outpatient palliative care department at the Radboud University Nijmegen 
Medical Centre were asked to participate in the study by their treating 
physician. Patients considered by their physician to be too ill to participate 
were not asked. 
Questionnaires and data collection 
Patients were asked to provide demographic information. The BDI-II and a 
single screening question “Are you feeling depressed?” were used to screen 
for depression. The BDI-II is a 21-item self-report questionnaire with four 
response options for each item. Items of the BDI-II relate to different 
symptoms of depression such as sadness, hopelessness, self-blame, guilt, 
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fatigue, and loss of appetite. On each item, patients are asked to choose the 
statement that best describes their attitude towards the item. Scores of the 
BDI-II can vary from 0 to 63 and are often classified as follows: 0–13 no 
depression, 14–19 mild depression, 20–28 moderate depression, and 29–63 
severe depression [29]. 
Patients were asked to fill out the questionnaire during their visit at the 
outpatient department or at home. The mood section of the PRIME-MD [30] 
was administered as a gold standard for the clinical diagnosis of a depressive 
disorder by the physician, who was blind to the results of the questionnaire. 
The PRIME-MD is a structured interview based on the DSM-IV classification 
for depressive disorder and has been validated in oncology patients [31]. 
The PRIME-MD provides standardized questions that focus directly on key 
diagnostic symptoms and a depressive disorder was diagnosed when 
patients fulfilled the DSM-IV criteria. The time required to complete the 
PRIME-MD mood section is approximately 10 min. 
Statistical analysis 
Statistical analysis was performed with SPSS 16.0. Means, sensitivity, 
specificity, and positive and negative predictive value were computed. A 
receiver operating characteristics (ROC) analysis was performed to 
determine the optimal cut score for the BDI-II as a screen for depression in 
this population. 
 
Results 
From December 2003 until March 2007, 61 patients (29 men, 32 women) 
were eligible to be included in the study. The inclusion period of this study 
has been relatively long because the outpatient department for palliative 
care patients was a new facility in the hospital and, consequently, referral 
numbers were low. Patients suffered from a variety of advanced cancers 
(23% colon carcinoma, 16% breast cancer, 8% head and neck cancer, 8% 
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lung cancer, 45% some other malignancy). Of the 61 eligible patients, 20 
patients (33%) deceased within 6 months. Seven eligible patients refused to 
participate in the study. 
Among the 54 patients who enrolled in the study, administration of the 
PRIME-MD was not completed in eight patients (Fig. 1). Therefore, complete 
data were obtained of 46 patients (26 women, 20 men, mean age 60 years, 
median age 58 years). The mean BDI-II score of the 46 patients who 
participated in the study was 14.7 (SD 9.9). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Inclusion of patients 
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Ten out of 46 patients (22%) were diagnosed with a major depressive 
disorder using the PRIME-MD. The area under the curve (AUC) of the ROC 
analysis of the BDI-II was 0.82 (Fig. 2). Using the traditional cut score of 14, 
the BDI-II demonstrated 90% sensitivity and 64% specificity. The positive 
and negative predictive values were 45% and 97%, respectively. However, 
using a higher cut score of 16 retained high sensitivity (90%) while increasing 
specificity to 69%. The positive and negative predictive values were 55% and 
96%, respectively. The single screening question demonstrated 50% 
sensitivity and 94% specificity. The positive and negative predictive values of 
the single screening question were 71% and 87%, respectively (Table 1). 
 
 
 
 
 
 
 
Figure 2. Receiving Operating Characteristic Beck Depression Inventory (BDI-
II) 
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Fig. 1: ROC BDI-II
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Table 1. Psychometric properties of single screening question and BDI-II 
 Sensitivity (%) Specificity (%) 
Positive 
predictive 
value (%) 
Negative 
predictive 
value (%) 
Single screening 
question 
50 69 71 87 
BDI-II (cut score 14) 90 64 45 97 
BDI-II (cut score 16) 90 69 55 96 
 
Discussion 
This study shows that the BDI-II is an adequate screening tool to detect 
depressive disorder in patients with advanced cancer. Using a cut-off point 
of 16, it has good sensitivity (90%) and acceptable specificity (69%). The 
single screening question performed unsatisfactory, demonstrating only 
50% sensitivity and 94% specificity. Given the consequences of not 
recognizing a depression in this vulnerable patient group and the possibility 
to rule out depression in further diagnostic assessment in patients who 
screen positive for depression, a high sensitivity and high negative predictive 
value of screening tools are important and a lower specificity and positive 
predictive value are accepted. 
The results of this study differ somewhat from previous findings on 
psychometric properties of the Beck Depression Inventory in a cancer 
patient sample. Katz et al. found that with a cut score of 16 the BDI had a 
sensitivity of 73% and specificity of 100% in a sample of 60 ambulatory 
patients with a malignancy of the head and neck region and identified the 
optimum cut score at 13 with a sensitivity of 92% and a specificity of 90% 
[32]. In the present study, the participants originated from a heterogeneous 
group of patients with advanced cancer, whereas Katz et al. used a more 
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homogeneous group of ambulatory head and neck cancer patients. 
Furthermore, Katz et al. used a different instrument, the Schedule for 
Affective Disorders and Schizophrenia, as a gold standard. 
A possible shortcoming of the BDI-II as a screening tool in advanced cancer 
patients is that the number of identified cases could be overestimated 
because of the somatic items of the questionnaire. The specificity of the 
BDI-II in advanced cancer patients might be increased by excluding the 
somatic items (e.g., weight loss, loss of appetite, etc.). The Beck Depression 
Inventory Short Form (BDI-SF), consisting of seven items tapping exclusively 
affective symptoms, might be more appropriate for this population. Love et 
al. performed a study in 227 women with metastatic breast disease in which 
the BDI-SF had a specificity of 63% and a positive predictive value of 0.52 
[33]. This needs further study to determine the psychometric properties in a 
more heterogeneous patient group. 
The sensitivity of the single screening question in this study appeared 50%, 
which is almost similar to the reported sensitivity of 55% in an earlier study 
in 74 palliative care patients [34]. Other previous studies, however, report a 
much higher sensitivity of a single screening question in palliative care 
patients (72–100%) [23, 35]. The low sensitivity of the single screening 
question in this study may point to difficulties regarding the meaning of the 
question. The word depression knows different translations and different 
interpretations in the Dutch language. The exact words that have been used 
might have influenced the results [36]. 
This study has some limitations. Firstly, the relatively small sample size was 
recruited from the recently started outpatient department for palliative 
care. Small sample size is not unusual in palliative care, in which recruitment 
is difficult and dropout rates are high due to deterioration of health status 
and death. Secondly, the selection of participants in this study was 
performed by the treating physician. The number of patients that the 
physicians considered too ill to participate was not recorded. In general, 
though, the participation of patients in research is high, when their 
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“personal” treating physician invites them for participation, but it might 
introduce selection bias if the physician leaves out highly distressed 
patients. Given the relatively high scores on the BDI-II in this sample, severe 
bias seems unlikely. Thirdly, we used the PRIME-MD as a gold standard. The 
PRIME-MD and other psychiatric interviews are not validated for advanced 
cancer patients specifically. However, they have been validated in cancer 
patients [31]. 
This study offers a contribution to the diagnosis and screening of depressive 
disorder in advanced cancer patients. The Beck Depression Inventory offers 
a method for brief and sensitive detection of depressive disorder in this 
specific group of patients. If used systematically in all advanced cancer 
patients, this screening tool may increase and improve physician’s 
evaluations of not only somatic, but also psychological complaints of their 
patients. 
To our knowledge, this is the first validation study of the Dutch Beck 
Depression Inventory and of a single screening question to screen for 
depression in a heterogeneous group of advanced cancer patients. Secondly, 
it gives a prevalence of depression in advanced cancer patients, based on a 
clinical diagnosis with the PRIME-MD, contrary to prevalence numbers 
acquired by questionnaires. In clinical practice, the screening tool can serve 
to alert physicians to the possibility of depressive disorder and hence give 
attention to the mental health status of palliative care patients, if necessary 
followed by further diagnostic assessment and appropriate treatment. 
 
Conclusions 
The BDI-II seems to be an adequate screening tool for depressive disorders 
in Dutch advanced cancer patients when using a cut score of 16. The single 
screening question is less adequate to detect depression in palliative care 
patients, considering the low sensitivity. 
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Diagnosing depression in patients with advanced cancer remains a 
challenge. Using a valid screening tool can facilitate the process of 
diagnosing depression in this specific group of patients. 
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Abstract 
Background: Patients in a palliative care trajectory frequently suffer from 
depression. To distinguish depression from normal sadness, the use of 
screening instruments could facilitate the diagnostic process. However, in 
palliative care, screening instruments may not discern physical symptom 
burden from psychological distress, due to the high number of physical 
symptoms in palliative patients. 
Objectives: The aim of this study was to explore physical symptom burden 
and psychological distress in patients with advanced cancer in relation to 
scores on screening instruments for depression. 
Methods: Patients with advanced cancer were asked to fill out the Beck 
Depression Inventory (BDI-II), Beck Depression Inventory Primary Care (BDI-
PC), Hospital Anxiety and Depression Scale (HADS), and Memorial Symptom 
Assessment Scale Short Form (MSAS-SF). The relationship between scores 
on screening tools for depression and different physical symptom clusters 
was explored. 
Results: In the sample of 65 patients, screening instruments for depression 
correlated highly with different somatic symptom clusters. The BDI-II 
cognitive subscale was the only scale that was not significantly correlated 
with any of the somatic symptom clusters. 
Conclusion: Screening tools for the detection of depression in patients with 
advanced cancer may not provide an accurate evaluation of depression. 
These tools seem to measure physical symptom burden as well, especially 
when patients suffer from symptoms of the clusters fatigue/anorexia/ 
cachexia, neuropsychology, debility, or pain. In this study, the BDI-II 
cognitive subscale seems to differentiate best from somatic symptom 
burden. 
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Introduction 
Patients in a palliative care trajectory frequently suffer from a wide range of 
physical and psychological complaints. In this conglomeration of symptoms, 
it can be difficult to diagnose mood disorders. Akechi et al.1 reported that 
the prevalence of major depressive disorder and adjustment disorders in 
incurable cancer patients is respectively 6.7% and 16.3%. However, in other 
studies, the reported prevalence of depression varies substantially from 1% 
to 69%.2 This large variation is possibly depending on the use of different 
screening or assessment tools for depression.3 Depression in palliative care 
patients is shown to be associated with poor outcomes in the palliation of 
physical symptoms, treatment adherence, and prognosis. Consequently, 
depression causes a burden for both patient and caregivers.4,5 Moreover, it 
is associated with increased disability, mortality, inpatient episodes, and 
healthcare costs.6-9 
In clinical practice, physicians are confronted with the challenging task to 
differentiate normal sadness and distress reactive to a palliative care 
situation, from pathological sadness or mood disorder that requires 
psychological or psychiatric intervention. Additionally, symptoms like 
fatigue, weight loss, concentration problems, and preoccupation with death 
that are common in depressive states, but also in terminal illness itself, can 
be confusing in making the correct diagnosis. Furthermore, both physicians 
and palliative care patients find it difficult to address emotional 
problems.10,11 This explains why the diagnosis of depression in these 
patients can be easily missed. A report from the European Association for 
Palliative Care indicates that depression may remain unrecognized in more 
than 50% of depressed medically ill patients.12 
The systematic use of a specific screening instrument for the detection of 
depression could be of value in the process of assessing palliative care 
patients for depression.13 However, a recent review demonstrated that 106 
different assessment methods are used for depression in palliative care and 
there is no consensus on which screening instrument is best for the specific 
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situation of a palliative care setting.14 Many screening instruments may 
measure distress without identifying the nature of the distress. The 
relationship between physical and psychological distress can be complex. A 
recent study showed that a high expression of physical symptoms in patients 
with advanced cancer is related to a high prevalence of mood disorders.15 
The Beck Depression Inventory (BDI-II), Beck Depression Inventory Primary 
Care (BDI-PC), and the Hospital Anxiety and Depression Scale (HADS) are 
validated screening tools in patients with cancer, and these screening tools 
are available in the Dutch language.16 Furthermore, HADS is suggested as a 
screening tool in Dutch palliative care guidelines.17 In this study, we explore 
depressive symptom burden as measured by the BDI-II, BDI-PC, and HADS in 
relation to physical symptom burden. We explore whether patients with a 
high or low score on screening instruments for depression differ in their 
physical symptom profile. 
 
Methods 
Sample and Design/Procedure 
This study was an observational questionnaire study. Patients included in 
this study were patients with advanced cancer who had an estimated life 
expectancy of 2 months to 1 year. Patients who were unable to speak or 
read the Dutch language or who suffered from cognitive dysfunction were 
excluded. 
From November 2008 to December 2009, ambulatory patients with 
advanced cancer were recruited from an academic oncologic and palliative 
care outpatient clinic and from different family practices that were affiliated 
with the Radboud University Nijmegen Medical Centre. 
The Institutional Ethical Committee of the Radboud University Nijmegen 
Medical Centre approved the study. Eligible patients selected by their 
physician received written information about the study and could give 
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informed consent. After obtaining informed consent, a questionnaire was 
sent to the patient to complete at home. The questionnaire contained 
questions concerning demographic information, the BDI-II, the HADS, and 
the Memorial Symptom Assessment Scale Short Form (MSAS-SF), which is a 
symptom burden questionnaire. The complete set of questionnaires 
contained 87 questions. Within 2 weeks after completing the questionnaire, 
patients were asked to complete the Beck Depression Inventory Primary 
Care (BDI-PC). This screening tool was not administered at the same time as 
the first questionnaire because all BDI-PC items are part of the BDI-II. 
Single omissions within the questionnaires were replaced with a mean score 
of the other questions on the (sub)scale. Whenever the answers for more 
than 2 questions on a (sub)scale were missing, the score on the (sub)scale 
was not used in the analysis. 
Questionnaires 
Demographics and History of Depression 
Patients were asked their age, civil state, socio-economic information, 
education, and whether they had a history of depression. 
Beck Depression Inventory and Beck Depression Inventory Primary Care 
The BDI-II is a 21-item self-report questionnaire to measure depression with 
4 response options for each item. A 3-factor model has been proposed for 
the BDI-II with a cognitive subscale (7 items), a somatic subscale (9 items), 
and an affective subscale (5 items).18 BDI-II scores can vary from 0 to 63. 
Originally, the BDI was developed to measure the severity of depression. 
The BDI-II is validated as a screening instrument in general populations as 
well as in patients with different kinds of physical illness, like chronic pain 
and myocardial infarction.19-22 The psychometric properties of the BDI-II 
proved satisfactory in oncology patients. Using a cutoff point of 14, it 
showed a sensitivity of 90% and a specificity of 86%.23 The BDI-II 
distinguishes itself from other assessment instruments for depression by the 
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relatively high number of psychological and cognitive items and therefore 
might be applicable in patients with physical illness.24 
The BDI-PC is a short form of the BDI-II developed to improve the screening 
of depression in patients with physical illness. This questionnaire consists of 
7 cognitive and affective items of the BDI-II. The BDI-PC with a cutoff point 
of 4 demonstrated a sensitivity of 82% and specificity of 82% in medical 
inpatients.25 The BDI-PC has been validated in patients with heterogeneous 
medical conditions.26,27 
Hospital Anxiety and Depression Scale 
The HADS is a 14-item, 4-point scale self-rating instrument for anxiety and 
depression developed for patients with both somatic and mental problems. 
Patients screen positive if they score 12 or higher on the total scale or 8 or 
higher on the subscales depression or anxiety.28 The HADS has been 
validated in the general population, in patients with cancer, and in the 
palliative care setting.16, 29-31 The HADS is suggested as a screening tool in 
Dutch palliative care guidelines.17 
Memorial Symptom Assessment Scale — Short Form 
The MSAS was developed to evaluate symptom prevalence, frequency, 
severity, and burden. The MSAS evaluates 32 physical and psychological 
symptoms. 
The MSAS has a high internal consistency and is reported to be a reliable 
measure of symptom distress in noncancer, as well as cancer patients.32 A 
shortened form of this scale (MSAS-SF), which symptoms are only evaluated 
on the burden that they cause, has been validated for patients with 
cancer.33 Within the MSAS- SF, 3 subscales have been identified by factor 
analysis in earlier research: distress, psychological symptoms, and physical 
symptoms.34 
Furthermore, derived from the MSAS-SF, different symptom clusters were 
described based on the clusters that Kirkova et al.35 describe in recent 
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studies. These clusters are fatigue/anorexia/cachexia cluster, 
neuropsychological cluster, upper gastrointestinal tract cluster, 
nausea/vomiting cluster, aerodigestive cluster, debility cluster, and pain 
cluster. 
Statistical Analysis 
Data were analyzed using SPSS 16.0 (IBM, Amsterdam, the Netherlands). 
Descriptive statistics were computed. The BDI-PC items were extracted from 
the BDI-II in order to examine the association between the scores. 
Correlations between different screening instruments, subscales, and 
symptom clusters were computed using Spearman’s rho for nonparametric 
data. Nonparametric tests (Mann–Whitney) were performed to explore 
whether patients with a high or low score on screening instruments for 
depression differed in their physical symptom profile. 
 
Results 
Patient Characteristics 
From November 2008 to December 2009, 175 patients were identified as 
eligible for this study. Of these patients, 86 gave informed consent of which 
20 patients dropped out because of fast deterioration or death. One patient 
dropped out because she did not match the inclusion criteria (Figure 1). 
Sixty-five patients completed the study (37% men, 63% women, age ranged 
from 45 to 89 years with a mean of 65 years). 
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All patients suffered from advanced cancer. Most frequent were patients 
with nephroblastoma (17%), colon carcinoma (20%), prostate carcinoma 
(14%), and breast cancer (11%). Other malignancies were carcinoma of the 
esophagus, carcinoma of the uterus, hepatocellular carcinoma, carcinoid, 
carcinoma of the pancreas, stomach cancer, glioblastoma, head and neck 
cancer, lung cancer, and thyroid cancer. Patient self- reported lifetime 
history of depression was 31%, and 10 patients (14.1%) had been treated 
with antidepressants previously. Eight patients (12.3%) were treated with an 
antidepressive agent during the time of the study. The actual reason for 
prescribing the antidepressive agent (depressive disorder, depressive 
complaints, neuropathic pain) was not known. 
Within 3 months, 10 patients (16%) and within 6 months, 21 patients (34%) 
had died. Table 1 shows survival time of the eligible patient group specified 
for participants and nonparticipants. 
 
Table 1. Survival time of eligible patients 
 Survival less than 3 months Survival less than 6 months 
Total group (N=175) 35 % 46 % 
Participants 20 % 35 % 
Non Participants 45 % 54 % 
 
Ten patients (15%) needed help from a caregiver with filling out the 
questionnaire. Most patients did not have any problems filling out the 
questionnaire and commented that the questions were easy to answer. 
Seven patients had 1 question missing on one of the questionnaires. Two 
patients did not fill out 1 of the 3 pages of the BDI-II, in which cases the BDI-
II was excluded from further analysis. 
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Depression, Anxiety, Distress, and Symptom Burden 
In this patient sample, using different screening tools with their cutoff point 
as proposed in the literature, depression was indicated in 24.6% using the 
BDI-II, in 23.1% using the subscale depression of the HADS and in 10.8% of 
patients using the BDI-PC. Using the HADS total score, 36.9% scored positive 
on distress and 15.4% scored positive on the subscale anxiety. 
The mean scores on different screening tools in this patient population are 
presented in Table 2. 
 
Table 2. Results of screening instruments for depression in patient sample 
(N=65) 
Screening instrument Percentage of patients that 
screened positive 
Mean (standard deviation) 
BDI-II (cut off 14) 24.6 % 11.8 (SD 7.7) 
BDI-PC (cut off 4) 10.8 % 1.9 (SD 2.3) 
HADS-T (cut off 12) 36.9 % 4.6 (SD 7.4) 
HADS depression (cut off 8) 23.1 % 5.7 (SD 4.2) 
HADS anxiety (cut off 8) 15.4 % 4.6 (SD 3.8) 
 
Symptoms in the MSAS-SF with a high prevalence (reported in more than 
40% of the sample) were lack of concentration; pain; lack of energy; anxiety; 
dry mouth; nausea; numbness of hands or feet; shortness of breath; feeling 
sad; worrying; lack of sexual interest; lack of appetite; irritability; change in 
taste perception; and weight loss. The mean total score on the MSAS-SF was 
23.2 (SD 17.8). 
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Association Between Different Screening Tools for Depression and Symptom 
Clusters 
The BDI-II correlated significantly with HADS scores and physical symptom 
burden measured with the MSAS- SF and its subscales: distress, 
psychological and somatic symptom burden. Furthermore, the BDI-II 
significantly correlated with the symptom clusters fatigue/anorexia/ 
cachexia, neuropsychology, debility, and pain. The clusters upper GI, 
nausea/vomiting, and aerodigestive were not significantly correlated with 
BDI-II scores. 
Both the somatic and affective subscales of the BDI-II were significantly 
correlated with the MSAS-SF and the subscales of the MSAS-SF: distress, 
psychological symptom burden, and somatic symptom burden. The 
cognitive subscale of the BDI-II was significantly correlated with the MSAS-
SF, the MSAS-SF subscales distress, and psychological symptom burden, but 
not with the subscale somatic symptom burden. The cognitive subscale did 
not correlate with any of the symptom clusters. 
The BDI-PC correlated with the MSAS-SF and its subscales and also 
significantly correlated with the BDI- PC that was computed from the BDI-II 
(r = 0.78, P < 0.0001). 
The HADS total score, the HADS subscale anxiety, and HADS subscale 
depression all correlated significantly with the MSAS-SF, as well as with the 
MSAS-SF subscale distress, MSAS-SF subscale psychological symptom 
burden, and MSAS-SF subscale somatic symptom burden. The HADS was 
significantly correlated with the symptom clusters 
fatigue/anorexia/cachexia, neuropsychology, and pain. The clusters upper 
GI, nausea/vomiting and aerodigestive were not significantly correlated with 
HADS scores. 
Correlations between different screening tools for depression and symptom 
clusters can be found in Table 3. 
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Differences in Symptom Clusters Between High- and Low-Depression Risk 
Patients as Defined by Scores on BDI-II, BDI-PC, and HADS 
Patients who scored positive for depression on the BDI- II (cutoff 14) 
significantly scored higher on symptom clusters fatigue/anorexia/cachexia 
and pain than patients who scored negative for depression. Patients who 
scored positive for depression on the BDI-PC (cutoff 4) significantly scored 
higher on symptom clusters fatigue/anorexia/cachexia, pain, upper GI, nau- 
sea/vomiting, and debility. Patients who scored positive for depression on 
the HADS (cutoff 12) significantly scored higher on symptom clusters 
fatigue/anorexia/ cachexia and neuropsychology. Patients who scored 
positive for depression on the HADS subscale depression (cutoff 8) 
significantly scored higher on symptom clusters fatigue/anorexia/cachexia, 
neuropsychology, and pain. 
 
Discussion 
This study presents a sample of 65 patients with advanced cancer in which 
different scores and sub scores on screening instruments for depression 
(HADS, BDI-II, BDI-PC) correlate highly with physical symptom burden. The 
BDI-II and HADS-D identified a high depression risk (patients scoring above 
the cutoff score) in respectively 24.9% and 23.1% of the patients. This 
prevalence lies within the range of earlier reported prevalence based on an 
assessment with the BDI-II and HADS (respectively, 10 to 39% and 9 to 
63%).36-39 
In this study, the highly significant correlations between the results of 
screening instruments for depression and physical symptom burden in this 
study indicate a strong relationship, which has also been found in previous 
studies that demonstrate that psychological and physical symptoms are 
strongly related and seem to have additive effects on each other.40-41 
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The BDI-II, specifically developed to measure depression, measures physical 
symptom burden as well in patients with advanced cancer. Symptoms from 
the clusters fatigue/anorexia/cachexia, neuropsychology, debility, and pain 
correlate especially highly with depression scores on the BDI-II. This is not 
surprising, as the symptoms fatigue and anorexia are part of the diagnostic 
criteria for depression. The cluster neuropsychology includes symptoms 
such as depression and loss of concentration. Furthermore, previous studies 
show that debility and pain are highly correlated with depression.15,42 
Because many physical and psychological symptoms in palliative care 
patients are interrelated, it can be difficult to know what we are actually 
measuring when using screening instruments for depression. In this study, 
the BDI cognitive scale differentiates best from somatic symptom burden as 
measured by the MSAS-SF. Forkmann et al.43 also conclude in their study 
that the use of a shortened version of the BDI-II with more emphasis on the 
emotional and cognitive items is preferred in patients with physical illness. 
In the context of terminal illness, there can be many somatic and emotional 
issues that are not directly related to depression or depressive disorder. 
‘Worrying’ or ‘rumination’ may be symptoms of depression in palliative care 
patients that can be better distinguished from symptoms of terminal illness. 
In screening questionnaires, this can probably best be measured by using 
items that measure the cognitive aspects of depression such as thoughts 
about past failures and self-criticalness. These items are well represented in 
the BDI cognitive subscale. 
This has been a monocentric study in which a mixed cancer patient sample 
was studied. A relatively large number of patients with nephroblastoma and 
relatively few patients with lung cancer have been included. This was due to 
the fact that the study was conducted in an oncology center where not all 
departments participated. The underrepresentation of patients with lung 
cancer, in particular, may limit the generalizability of the findings of this 
study in other palliative care populations. 
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Unfortunately, data on the BDI-PC could not be obtained at the exact same 
moment as the other questionnaires so the conditions of the patients might 
have differed in both moments of measurements. However, it was managed 
to obtain all data within 2 weeks. Furthermore, the correlation between the 
BDI-PC and the BDI-PC items extracted from the BDI-II was very high, 
indicating little change in mood in this short time period. 
In this study, there was a high dropout rate due to nonresponders (31%) and 
refusal to participate in the study (20%), which is not unusual in patients 
with advanced cancer in which recruitment is difficult and dropout rates are 
high due to deterioration of health status and death.44 
The treating physician asked patients to participate in this study. The 
number of patients who the physicians considered too ill to participate was 
not recorded. In general, the participation of patients in research is higher, 
when their ‘personal’ treating physician invites them for participation, but it 
might introduce selection bias if the physician leaves out highly distressed 
patients. Given the relatively high scores on the BDI-II in this sample, we 
think severe bias is unlikely, although there appears to be a bias toward a 
patient group with a better survival because the number of patients who 
died within 3 to 6 months in the eligible patients who did not participate 
was higher than the group of patients who did participate in this study. 
Furthermore, the patient sample could be biased because patients with a 
high symptom burden (psychological or somatic symptom burden) and 
especially depressed patients might refuse participation in a study more 
often than patients with a low symptom burden. 
This study offers a critical reflection on the use of screening instruments for 
depression and distress in palliative care patients. The complex relationship 
between physical and psychological distress can hamper active case finding 
for depression in palliative care. It is likely that we measure different 
dimensions of distress with different screening tools for depression. 
Especially in patients suffering from symptoms in the cluster 
fatigue/anorexia/cachexia, neuropsychology, debility, and pain, the somatic 
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symptoms are highly correlated with scores on screening tools for 
depression. Thus, interpreting the results of screening tools in these patients 
may be more challenging and a complete assessment is indispensable. The 
search of finding the most valid screening tool for depression in palliative 
care patients is complex, and in patients with different physical symptom 
profiles, we might need different screening tools. Therefore, we recommend 
direction of our attention to screening tools that, depending on the clinical 
context, can identify patients’ needs rather than assess distress or 
depression.45 Eventually, clinical relevance of screening for depression may 
not be the identified number of patients with depressive disorder, but the 
number of distressed patients who, as a result from screening, can benefit 
from an intervention that they would otherwise not have received. 
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“As no two persons are alike in health, so no two are 
alike in disease; and no diagnosis is complete or exact 
which does not include an estimate of the character 
or constitution of the patient…. For to treat a sick 
man rightly requires diagnosis not only of the disease 
but the manner and degrees in which its supposed 
essential characters are modified by his personal 
qualities, by the inheritances that converge in him, by 
the changes wrought in him by the conditions of his 
past life, and many things besides.” 
 
James Paget (1814-1899) 
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Abstract 
Background: Facing a terminal illness can be highly stressful and palliative 
care patients frequently suffer from mood symptoms. The focus of health 
care is often on treating symptoms whereas health-promoting factors 
receive less attention.  
Objective: The aim of this study was to explore the views of palliative care 
patients on resources and ways of coping that help them prevent or manage 
mood symptoms. 
Methods: A pilot qualitative study was performed through face-to-face 
semi-structured interviews with fifteen ambulant patients with advanced 
cancer. The interviews were transcribed verbatim and qualitative analysis 
was independently performed by two researchers, according to the principle 
of constant comparative analysis. 
Results: Patients reported on attitudes and specific coping strategies that 
they found helpful, as well as aspects of their life narrative and spirituality. 
Resources were found in meaningful contacts with family and friends and in 
personal attention of professional medical caregivers for their wellbeing.  
Conclusion: We conclude that when palliative care patients experience 
mood symptoms, they could identify resources to cope with these 
symptoms in the context of their unique life. 
Implications for practice: If patients are given an active role in the care team 
in addressing, activating and enhancing personal resources their autonomy 
could be enhanced. 
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Introduction 
Living with a terminal illness is a highly stressful situation, causing 
substantial impact on the way patients relate to their social network and 
their way of living (Thoresen et al., 2011). Patients in palliative care 
frequently report a variety of physical and psychological symptoms (Osse et 
al., 2005) including depressive symptoms, which may be part of a depressive 
disorder. The prevalence of depressive disorders in the palliative trajectory 
varies widely from 3 to 77% (Hotopf et al., 2002; Stiefel et al., 2001) due to 
differences in definition, classification and methods of assessment. A 
depressive disorder is mostly considered as a psychiatric illness for which 
interventions such as psychotherapy or medication are available (Akechi et 
al., 2008). Depressive disorders in patients in palliative care are associated 
with poor outcomes in the palliation of physical symptoms, treatment 
adherence, prognosis, and result in increased disability, inpatient episodes 
and healthcare cost (Irving and Lloyd-Williams, 2010; Lloyd-Williams et al., 
2008; Lloyd-Williams et al., 2009; Rayner et al., 2011; Reeve et al., 2008). 
Therefore depressive disorders cause a burden for both patients and 
caregivers (Chochinov et al., 2007; Henoch et al., 2007). 
Some, however, consider a depressive disorder as a normal reaction to 
‘something bad happening’ (Dowrick, 2004). In this latter view, the absence 
of a depressive disorder, or even reports of positive mood or emotions, in 
the context of a terminal illness are perhaps more surprising than the 
presence of a depressive disorder. Positive emotions may broaden an 
individual’s repertoire in reaction to adverse events and reinforce an 
individual’s personal resources (Fredrickson, 2001). A recent study 
confirmed this theory and suggested that upward spirals of positive 
emotions can counter downward spirals of negativity (Garland et al., 2010). 
Antonovsky emphasized origins of health in a model that identifies three 
foundations for successful coping: comprehensibility, manageability and 
meaningfulness (Antonovsky and Sagy, 1986). Whereas our healthcare 
system emphasizes the treatment of diseases and symptoms, a growing field 
of research is reflecting on ways to enhance health-promoting factors, 
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inferring that these are also important in preventing disorders (Lindstrom 
and Eriksson, 2005). 
The aim of palliative care is to improve the quality of life of the individual 
patient by proactive identification of problems and delivering patient-
centered multidimensional care (Lloyd-Williams et al., 2008). It has been 
shown that adequate coping strategies can positively influence mood in 
palliative care patients (van Laarhoven et al., 2010), but little attention has 
thus far been given to palliative care patients’ actual experience of effective 
ways of coping and resources. This hampers the possibility to build palliative 
care upon self-empowerment. Preventive, context-related interventions 
such as those derived from positive psychology (Seligman et al., 2005), can 
empower patients in a palliative care trajectory to rely on personal 
resources and ways of coping when facing terminal illness.  
This exploratory study analyses the views of patients in a palliative 
trajectory on resources and ways of coping that help them prevent or 
manage mood symptoms in facing terminal illness and end of life decisions. 
 
Methods 
A qualitative study was performed through face-to-face semi-structured 
interviews with patients with advanced cancer in a palliative care trajectory 
with a life expectancy (estimated by their physician) between two months 
and one year. 
This study was part of a larger study in which 65 palliative care patients 
were included in a diagnostic study on depressive disorder (Warmenhoven 
et al., 2012b). Patients who were unable to speak Dutch or who suffered 
from cognitive dysfunction were excluded from this study. Part of the 
diagnostic study consisted of a face-to-face psychiatric interview (Schedules 
for Clinical Assessment in Neuropsychiatry 2.1) to assess a possible 
depressive disorder. After the structured psychiatric interview, patients 
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were asked the following open question: ‘What helps you to prevent or 
address mood symptoms in the context of your terminal illness?’. The 
conversations following this question were recorded on audiotape. The 
interviews took place from December 2008 until November 2009. The 
current qualitative study reports about individual interviews with palliative 
care patients. For this pilot study fifteen palliative care patients were 
selected using purposive sampling based on age and sex. Furthermore we 
selected about half of the patients who had a Beck Depression Inventory 
(BDI-II) depression score above a cut-off score of 16, and the rest of the 
patients with scores below the cut-off score (Warmenhoven et al., 2012a).  
The interviews were transcribed verbatim and qualitative analysis of data 
has been independently performed according to the principle of constant 
comparative analysis (Cutcliffe, 2005; Strauss, 1987) by the interviewer and 
a second researcher. Both researchers coded the transcripts thematically 
and categorized relevant and meaningful fragments with the aim of creating 
structure in relevant themes. This process was carried out using ATLAS.ti 
4.2, a software program for qualitative data analysis. After analyzing seven 
interviews, the emerging codes and themes were discussed until consensus 
was reached. The following eight interviews were analyzed using the codes 
and themes that had emerged from the first seven interviews; codes or 
themes were added when needed. During the qualitative analysis, themes 
were continuously checked against the transcripts to ground the themes in 
the data. 
 
Results 
Eight women and seven men participated in this study. Patients had a mean 
age of 65 years with a range of 51-89 years. On inclusion patients had a 
mean score on the BDI of 15.9, with a range from 5-35 (table 1). None of the 
patients were suffering from a depressive disorder or anxiety disorder as 
assessed with the diagnostic interview. Three men and four women 
reported a history of depression. The median time that had passed since 
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receiving the bad news of having an incurable illness was 22 months, with a 
range from 1-115 months. 
 
Table 1. Patient characteristics 
 Men Women Total 
N 7 8 15 
Age (mean and range) 66 (range 51-89) 65 (range 52-75) 65 (range 51-89) 
BDI (mean and range) 15.3 (range 6-35) 16.5 (range 5-26) 15.9 (range 5-35) 
Self-reported history of 
depression (N=) 
3 4 7 
Months since receiving 
diagnosis of incurable illness 
(median and range) 
27 (range 2-114) 9 (range 1-115) 22 (range 1-115) 
 
Patients named resources or ways of coping that they experienced as 
helpful in preventing or addressing mood symptoms. In the answers to the 
question ‘What helps you to prevent or address mood symptoms in facing 
your terminal illness?’, we could distinguish resources and ways of coping 
that were directly related to the patient, resources that were related to the 
patient’s social network and resources that were related to professional 
support. 
Patient’s resources 
Patients reported about how their life narrative helped them to face their 
terminal illness. They reported experiences and memories from the past 
that helped them in the situation that they currently faced. Furthermore 
patients reported that it was helpful that they could look back at their life 
with satisfaction and without the sense of leaving unfinished business 
behind.  
 
Chapter 6 
97 
 
P. 4: ‘…for a while, after I did not have to work anymore, I have been helping 
out as a volunteer in supporting disabled persons on their holiday. And then 
you actually learn a lot…..that there are other people and things can be 
different…….’ 
P. 11: ‘I always loved to go to work. Very much so. I have always worked very 
hard. I did not make weeks of forty hours, but I [started] in the morning at 
three - four am and I returned home at ten pm. On Friday at five am and 
Saturday afternoon home at three pm. Then I did not see my bed at all, at 
the bakery. It was always very nice work.’ 
P. 12: ‘I have had a very nice life. So, for me….well of course there are always 
things of which you could say: I would have liked it better this way or that 
way……but I have had a very nice life and…..a good marriage….not without 
any fight, I mean, there were also…..sometimes there were problems, but 
that was never paramount…’ 
P. 12: ‘Well, I have the idea, but again, you never know, that there are no 
unfinished things….I do not have to think: this needs to be…..with this person 
I need to reconcile……so yes, things are ok….I am at peace.’ 
P. 1: ‘Although I have been raised protestant, I developed my own opinions 
about this, about life. Including dying. I have developed this and yes, that’s 
what I build on.’ 
Patients reported different helpful behaviors or attitudes to address mood 
symptoms. They reported that they used ways of dealing with difficulties 
that had been proven effective in their past experiences. Attitudes that were 
experienced as helpful were optimism, being able to experience and enjoy 
the moment, being grateful for the moment, being able to take decisions, 
taking an active stance in life, a fighting spirit in combination with meekness 
to the inevitable, humor and being able to reflect on their own feelings and 
behaviors. Spirituality was experienced in religious rituals by some patients 
and in non-religious experiences (e.g. nature or connectedness with other 
people) by others. Active awareness of spirituality helped patients to feel 
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connected with something larger. They felt they could surrender to 
something higher and sometimes participated in supporting rituals. Specific 
coping strategies like active problem solving, living with their limitations in a 
flexible way, distracting themselves, taking good care of themselves, 
undertaking various (physical) activities and living life as normal as possible 
were identified as helpful. 
P.1 :‘I am, yes, every human being is religious, you could say, but…..my view 
on life is just…..you come at a certain moment and you don’t choose this 
yourself. And you go at a certain moment and you don’t choose that either.’ 
P. 8: ‘I love to enjoy nature and those kinds of things. …..We [patient and 
partner] did a bird course together for example. Our children thought it was 
deeply insane [laughs], but we think it’s incredibly fun and if we see a 
woodpecker when we take a walk, then we are completely happy [laughs]. 
Yes, that is what spirituality means to us.’ 
P. 15: ‘I pray twice a day. For all the people that have died.’ 
P. 4: ‘I don’t give in. I, yes, actually, I still try to do everything. ………normally 
[this activity] takes ten minutes. Well, it takes me one hour. …..And I could 
say that it used to take me only a little while, and now every time it takes me 
longer than back then. But I am happy and thrilled that I can still do it, that I 
am still able…..’ 
P. 4: ‘Everything I can do, that I can still enjoy, I do.’ 
P. 8: ‘So it is not only negative. I don’t see it that way. There are, of course, 
many negative things about it, but yes, life is still very much worth living.’ 
P. 14: ‘It is a surrender. To life, or destiny. I don’t have to fulfill that anymore’ 
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Social network 
Patients with a partner experienced the care of their partner as essential. A 
sense of connectedness with a larger community (family, church, village) 
was reported to be helpful. Some patients reported that communication 
with other people was very supporting. They actively looked for meaningful 
contacts and interactions. Explicitly being of significance to other people 
was reported to be important. 
P. 9: ‘That’s the most important thing in life, isn’t it, that I am still useful for 
people and that the people that live around me are still useful to me’ 
P. 15: ‘I have a daughter who came to the radiation therapy 32 times. All 
these days.…. That’s positive….I am very happy about that’ 
P. 14: ‘If it becomes too much for me, I look for someone to talk with, for a 
while. So I can….that is…how shall I say this…in my own environment I 
cannot share much with people, except for my friends and daughter. So 
then…. I used to go to a course and there I would always find my kind of 
people. And now I have found someone to talk to through an organization of 
volunteers…… he used to be a priest. He is married and very involved in 
Buddhism. Yes, then you can speak with each other for a while and that 
brings something different…….yes, for example we exchange books, and then 
we talk about it.’ 
Professional support 
Patients valued a genuine interest of their professional caregivers in their 
wellbeing. Some reported that professional psychological care had been 
helpful. Patients also reported that it would be helpful if medical caregivers, 
like physicians and nurses, would more frequently ask about their wellbeing. 
P. 9: ‘I went to Mrs. A [a psychologist], because I had difficulty 
communicating with my daughter because we have such conflicting opinions 
and I thought: we must not let this happen. So let’s find help.’ 
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P. 11: ‘….the doctor will probably walk in this evening, he always comes 
walking in and out, once a week. …….we drink coffee and we talk for a 
while…..that is really great.’ 
P. 9: ‘It would be nice if something was offered. And maybe not specifically, 
but if they would, for example, if the specialist checks my breathing, checks 
whether my abdomen hurts etc., she could also ask if I am still feeling happy. 
Or if I am, I don’t know, crying more, or something like that……because that 
is not what she is asking. It would be nice if that was asked, because then 
you at least have an opportunity to talk about it. It could well be that there is 
no-one at home talking with you about it.’ 
 
Discussion and conclusion 
Discussion 
This study reports self-reported resources and ways of coping that help 
patients to prevent or manage mood symptoms in facing terminal illness 
using qualitative research methods. Patients reported about attitudes and 
specific coping strategies that they found helpful, as well as aspects of their 
life narrative and spirituality. Furthermore resources were found in 
meaningful contacts with family and friends and in personal attention of 
professional medical caregivers for their wellbeing. 
Some of the self-reported resources that were identified in this study have 
been studied previously. Both an accepting stance towards the situation as 
well as an active attitude, as reported by patients in this study, have been 
found by Laarhoven et al. as being predictive for a better quality of life and 
lower levels of depression and hopelessness (van Laarhoven et al., 2010). A 
recent review concluded that active, problem-focused coping in advanced 
cancer patients seems adaptive (O'Brien and Moorey, 2010) which may be 
related to the ‘active stance towards life’ that patients in this study identify 
as being helpful. This quality of an ‘active stance towards life’ may also be 
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related to the findings in a recent study in cancer patients in which goal 
reengagement, active coping and acceptance were reported to be 
significantly related to positive change (Schroevers et al., 2011). In previous 
studies, practicing and experiencing religious rituals or spirituality seemed to 
be beneficial for quality of life in the context of palliative care (Sinclair et al., 
2006; Vallurupalli et al., 2012). Earlier studies on social resources showed 
that a lack of social support was a predictor of non-remission for depression 
(Goodwin et al., 2011). 
Every palliative care patient experiences his symptoms or moods in the 
context of his unique life and therefore seems the most relevant person to 
identify personal resources. Previous research shows that physicians can 
help patients with medical problems to identify and mobilize self-assessed 
personal health resources (Hollnagel et al., 2000; Malterud and Hollnagel, 
1997, 2004). Considering this, palliative care patients could be given an 
active role in the care team in addressing, activating and enhancing personal 
resources to address mood symptoms. This could enhance their autonomy 
in creating or enhancing upward spirals of emotions and experience positive 
affect, which may be much more effective to counter the downward spiral 
of emotions that seem inevitable in the palliative care context (Fredrickson, 
2001).  
In this study a differentiated sample of patients was used, including men 
and women in a palliative trajectory, varying in age, depression score on the 
BDI-II, history of depression and time since the diagnosis of an incurable 
illness. Each researcher performed the analysis independently. No cyclic 
analysis procedure was used, however, which makes it possible that themes 
were missed. A further limitation of this study is that it is not clear whether 
patients verbally identifying resources can also use and enhance these 
resources and whether the personal resources are effective in alleviating 
mood symptoms.  
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Conclusion 
In this study palliative care patients seem to welcome active exploration of 
their mood by healthcare professionals and can identify their personal 
resources to prevent or address mood symptoms. Although negative aspects 
of mood, such as symptoms and behavior of sadness or grief, are expected 
in a palliative care context, the findings of this study encourage also 
attending to positive experiences and behavior of patients in a palliative 
care setting. Palliative care patients can be encouraged to identify personal 
resources that are accessible and available in their specific context. The 
search for positive resources could offer a more inclusive and realistic view 
of the palliative care context in which both negative and positive aspects are 
attended to. In helping patients to identify their personal resources, patient 
autonomy in enhancing resilience could be increased. In this process it is 
essential that healthcare professionals invite patients as partners in the 
communal process of providing palliative care. Further research in this field 
is necessary to clarify the effectiveness of actively involving patients in 
identifying and strengthening personal resources. In addition, more research 
on specific interventions that can possibly support this process in the end of 
life phase, such as dignity therapy (Chochinov et al., 2011), narrative therapy 
(Stanley and Hurst, 2011) and other psychological interventions, is needed.  
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“A physician is obligated to consider more than a diseased organ, 
more even than the whole man - he must view the man in his world.” 
 
Harvey William Cushing (1869 – 1939) 
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Abstract 
Purpose: Depression is highly prevalent in palliative care patients. In clinical 
practice, there is concern about both insufficient and excessive diagnosis 
and treatment of depression. In the Netherlands, family physicians have a 
central role in delivering palliative care. We explored variation in family 
physicians’ opinions regarding the recognition, diagnosis, and management 
of depression in palliative care patients. 
Methods: We conducted a focus group study in a sample of family 
physicians with varied practice locations and varying expertise in palliative 
care. Transcripts were analyzed independently by 2 researchers using 
constant comparative analysis in ATLAS.ti. 
Results: In 4 focus group discussions with 22 family physicians, the 
physicians described the diagnostic and therapeutic process for depression 
in palliative   care patients as a continuous and overlapping process. 
Differentiating between normal and abnormal sadness was viewed as 
challenging. The physicians did not strictly apply criteria of depressive 
disorder but rather relied on their clinical judgment and strongly considered 
patients’ context and background factors. They indicated that managing 
depression in palliative care patients is mainly supportive and nonspecific. 
Antidepressant drugs were seldom prescribed. The physicians described 
difficulties in diagnosing and treating depression in palliative care, and gave 
suggestions to improve management of depression in palliative care 
patients in primary care. 
Conclusions: Family physicians perceive the diagnosis and management of 
depression in palliative care patients as challenging. They rely on open 
communication and a long-standing physician-patient relationship in which 
the patient’s context is of great importance. This approach fits with the 
patient-centered care that is promoted in primary care. 
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Introduction 
Mood disturbances are common in palliative care patients. When 
confronted with a patient on a palliative trajectory who reports feeling sad, 
it can be challenging to differentiate depression from normal sadness. The 
prevalence of major depression and adjustment disorder in patients with 
advanced cancer is 6.7% and 16.3%, respectively.1 Depression in palliative 
care is associated with poor treatment adherence, increased difficulties in 
relieving physical symptoms, disability, poor prognosis, higher mortality, 
longer inpatient stays, and elevated health care costs.2-6 
Consequently, recognition, diagnosis, and treatment of depression are 
important. Health care professionals face the dilemma that active screening 
for and treatment of mood symptoms are encouraged, but may lead to 
overtreatment and medicalization of normal sadness.7-9 In palliative care, 
this dilemma may be accentuated because mood symptoms can be related 
to the stress of facing terminal illness. 
Palliative care is integral health care in which, in most countries, family 
physicians play an important role.10,11 Family physicians find it difficult to 
achieve balance between supporting and empowering patients with 
depressive symptoms, and actively treating patients with a depressive 
disorder.9,12,13 This difficulty could be even more prominent in palliative 
care, where physical symptoms and grief may hamper the interpretation of 
mood symptoms.5, 14-16 
The aim of this study was to explore the variation in the opinions of family 
physicians regarding the recognition, diagnosis, and management of 
depression in palliative care patients, and to ascertain their suggestions for 
optimizing this process. 
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Methods 
Design and Setting 
The study took place in Dutch primary care. In the Netherlands, everyone is 
obliged to have private health care insurance, with all insurance plans 
providing care through family practice. Most palliative care patients want to 
die at home, with their family physician as the main professional caregiver.17 
To study the perception of family physicians with regard to depression in 
palliative care patients, we used focus group discussions. A focus group 
study is considered an appropriate method to explore existing opinions 
about complex issues.18 
Participants 
We used purposive sampling to obtain a sample of family physicians from 
different locations and with varying expertise in palliative care. The sample 
consisted of 4 groups: (1) an existing continuing medical education group of 
physicians, discussing topics on a monthly basis; (2) a group of physicians 
whose practices were affiliated with the Radboud University for graduate 
studies in medicine; (3) a group of physicians of affiliated practices who had 
extensive expertise in palliative care; and (4) a group of physicians who were 
not affiliated with a university and whose practices were located in the 
South of the Netherlands. Group 1 had 8 physicians. The members of groups 
2 and 3 were recruited by sending invitations to 300 family physicians; 61 
physicians responded, of whom 8 were willing and able to participate in 
these groups. We selected the physicians with expertise in palliative care on 
the basis of participation in education, work, or research in this field. Finally, 
of 24 physicians invited, 6 physicians were willing and able to participate in 
group 4. All physicians were paid a modest fee for their participation. 
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Questionnaire 
Each focus group participant answered a questionnaire on demographics, 
work experience, type of practice, religion, attitudes toward the use of 
screening instruments to diagnose depression, and the average number of 
palliative care patients they supported in 1 year. Additionally, using a 10-cm 
visual analog scale, participants were asked to indicate their expertise in 
palliative care and in mental health; higher scores indicated greater 
expertise. 
Focus Groups 
An experienced, independent moderator (K.vS.) guided the focus group 
discussions with the topic list shown in Table 1. The topic list was developed 
from the literature and guidelines on depression in general and in palliative 
care.19-22 It focused on attitudes, problems, and needs in the management 
of depression in palliative care. 
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Table 1. Topic List Focus Group ‘Depression in palliative care patients’  
Identification of depression in palliative patients: 
 How do you recognize depression in a palliative patient? 
 Which specific complaints trigger you to think of depression? 
 What role do informal caregivers play in the assessment of depression? 
 How often do you recognize depression in a palliative patient? 
 Do you recognize or diagnose depression more easily in your palliative care 
patients after gaining more knowledge and experience in palliative care due to 
education and training?  
 How would you describe the process of diagnosing depression in a palliative 
patient? 
 Do you use guidelines or standards in diagnosing depression in a palliative patient? 
 What difficulties do you experience in diagnosing depression in a palliative 
patient? 
 Have you experienced that you missed a diagnosis of depression in a palliative 
patient or have recognized it (too) late? 
Management of depressive symptoms in palliative patients: 
 What is your general management for depression in palliative care patients? 
 What is your specific management for depression in palliative care patients? 
 Did your approach of depression in palliative care patients change after gaining 
more knowledge and experience in palliative care? 
 How do you perceive your role as a doctor in managing depression in palliative 
care patients? 
 How are partners, spouses and other close relatives of a palliative care patient 
involved in managing depression in palliative care patients? 
Needs and solutions 
 What is needed in primary care to improve the identification and management of 
depressive complaints in the palliative phase? 
 
At the start of the focus group discussion, we gave a definition of a palliative 
care patient, describing someone having a progressive, incurable illness, 
with a life expectancy of less than 1 year but more than a few weeks. We 
used this definition to direct the discussion to the care of patients on a 
palliative trajectory but not yet in the terminal phase of their illness. 
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We did not predefine depression because we wanted to observe physicians’ 
implicit and explicit opinions on its definition. After briefly describing the 
group procedure, the moderator introduced each topic on the list, and each 
participant was invited to give   his or her view. This step was followed by a 
group discussion in which the moderator actively motivated participants to 
explore and clarify their views more in depth. All focus group discussions 
were recorded and transcribed verbatim. 
Data Analysis 
We used constant comparative analysis to analyze the data.23,24 During this 
process, themes were continuously checked against the transcripts to 
ground the themes in the data using ATLAS.ti 4.2 (ATLAS.ti Scientific 
Software Development GmbH). 
The analysis started immediately after the first focus group and continued 
after each subsequent group. Two researchers (F.W. and E.vH.) 
independently coded the transcripts and categorized meaningful fragments 
to create structure in relevant themes. After each group, the codes were 
compared and discussed until agreement was reached. Subsequently, the 
codes were discussed with a third experienced researcher (E.vR.), to 
enhance rigor. We added important new themes to the topic list for 
consecutive focus groups until saturation was reached.18,25 
 
Results 
Participants and Procedure 
Our purposive sampling resulted in 4 focus groups having a total of 22 family 
physicians (13 men, 9 women; 4 to 8 participants per group). The physicians’ 
characteristics are given in Table 2. The focus group sessions lasted 
approximately 90 minutes and took place between February and April of 
2010.  
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Table 2. Characteristics of family physicians  
General characteristics Number of family physicians 
Male 
Female 
13 
9 
Full time٭ 
Part time 
12 
10 
Urbanization of practice 
Rural 
Suburban 
Urban 
 
6 
9 
6 
Experience and expertise Mean Range 
Experience as a family physician 
Number of patients in their practice 
Estimated number of palliative patients per year 
VAS score expertise palliative care 
VAS score expertise mental health care 
18 
4575 
11.5 
6,7 
6,4 
(3-33) 
(1850-7300) 
(3-20) 
(3,4 – 8,4) 
(2,9 – 7,9) 
٭Full time: 80% -100% full time 
The results of the focus groups are split into 4 main categories: diagnosis of 
depression, management of depression, difficulties in this area, and needs 
and possible solutions. Below, we present different themes within each 
category. 
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Diagnosis of Depression 
Depression Terminology, and Normal vs Pathologic Sadness 
The family physicians reported that they regularly noticed a depressed 
mood, anxiety, sadness, and worry in palliative care patients, and generally 
felt competent to address these symptoms. They qualified emotional issues 
as understandable and appropriate in the process of accepting the end of 
life, and although they actively addressed these issues, they did not apply 
the medical concept of depression. They described difficulty in 
distinguishing normal from abnormal sadness, as the following comment 
illustrates: 
I don’t see it [depression] very often and I notice I have the tendency to ignore the 
medical concept [of depression] a little bit...I don’t believe that at one point, a 
depressed mood starts and at another point, depressive disorder begins. There is of 
course a big transitional area, and it depends on the situation, the patient, and the 
doctor...I can’t remember that I have ever actively looked for depression in a 
palliative patient (family physician [FP] D, focus group [FG] 1). 
Interpreting Signs and Symptoms: Nature, Gravity, Consistency, and 
Expectations 
The family physicians identified specific signs and symptoms that they 
related to depression: severe and persistent depressive feelings without 
moments of enjoyment or relief; flat affect; untreatable physical symptoms, 
or more suffering than would be expected from the medical condition; 
behavior that resulted in isolation and emotional distance from relatives and 
caregivers; a lack of growth toward accepting the end of life; and negative 
feelings or behavior that were not expected given the patient’s character 
and background. As one physician stated: 
The moment I think a person with cancer in this phase is depressed, then it [the 
behavior] has to differ from the pat- tern you expect there to be...and because you 
are a FP, you know how a patient normally reacts and whether it fits with the way I 
expect him to deal with this situation (FP H, FG 2). 
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The physicians reported that they often perceived the Diagnostic and 
Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) definition of 
depression as incompatible with the context of palliative care. They believed 
that the consistency and seriousness of the main symptoms of depression 
(depressive feeling and anhedonia) were important for diagnosis; however, 
they viewed additional criteria of depression, such as fatigue, weight loss, 
and anorexia, as inappropriate. 
The Diagnostic Process: Observation, Communication, Screening Tools, and 
“Gut Feeling”  
When asked how to diagnose depression in palliative care, the family 
physicians underscored the importance of mapping cognitions, social 
system, and the context of the patient to establish potentially changing 
patterns in feelings and behavior as a sign of psychological dis- tress. To 
explore the character, seriousness, and origin of depressive feelings, the 
physicians reported that they dis- cussed these aspects in open conversation 
with patients and, when relevant, also with partners and relatives. 
They used the question “Do you feel depressed?” and saw it as useful for 
assessing the possibility of depression. Most physicians indicated that they 
relied on their clinical judgment and “gut feeling” rather than on screening 
instruments. 
Management of Depression 
General Management: Context, Attention, Communication, Support, and 
Autonomy 
Whether or not the family physicians labeled patients as depressed, they 
stressed the importance of paying attention to depressive and anxious 
feelings; patients’ cognitions, existential questions, and spiritual needs; and 
the perceptions and feelings of partners. They reported that they attended 
to the psychosocial con- text early in the palliative phase to anticipate 
problems. Intensive support, frequent visits, and open communication were 
important tools in their management of depression. The physicians had 
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observed that patients and families who felt that they could rely on their 
physician’s support experienced less anxiety, more peace   of mind, and 
decreased stress. Furthermore, physicians reported that they encouraged 
patients to make their own decisions in the palliative care trajectory as a 
means to increase their autonomy. 
Specific Management, Referral, and Pharmacologic Treatment 
Several family physicians reported that they sometimes found it helpful to 
refer patients to a psychologist, social worker, or palliative care team for 
support. 
Physicians reported that they seldom prescribed antidepressants or 
stimulants, but those with greater expertise in palliative care indicated that 
they were more comfortable with diagnosing depression and deciding on 
pharmacologic treatment. The choice of medication was based on the 
nature of the psychological symptoms, the patient’s age and life expectancy, 
comorbidities, and expected adverse effects. 
Physicians who treated with antidepressants emphasized the importance of 
intensive support, especially in the beginning of the treatment, to increase 
treatment adherence. Pharmacologic treatment was always used in 
combination with psychotherapy or support. 
Difficulties in Providing Palliative Care 
Interfering With the Natural Process 
The family physicians were reluctant to focus on depressive feelings out of 
fear of interfering with the process of patient adaptation, by negatively 
labeling it. Especially when it came to specific management, they expressed 
uncertainty. They often approached the possibility of depression indirectly 
with the patient, preserving a balance between focusing on patients’ 
personal experiences and proactively managing depression. In view of this 
reservation, some physicians hesitated when it came to decisions about 
managing depressive symptoms with medication or psychotherapy. As one 
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physician articulated: 
“I will not easily treat with antidepressants or diagnose depression because I don’t 
want to interfere in the process of accepting the end of life” (FP V, FG 1). 
Context and Uniqueness of the Patient 
The family physicians emphasized the unique, dynamic situation of every 
patient that, in their opinion, made it difficult to follow general guidelines 
for diagnosis and management of depression, or even a specific guideline for 
depression in palliative care. 
Time, Knowledge, and Focus of Attention 
Time pressure was acknowledged as a structural barrier in palliative care in 
general and specifically in dealing with psychological issues. It limited 
conversations with patients and their partners. 
Some physicians found it difficult to address the complete spectrum of 
palliative care, in particular, to discuss psychological or social aspects with 
patients and partners who were focused on the physical illness, as 
illustrated by the following comment: 
When you’re very busy with all the somatic issues and symptoms and the 
management of the whole palliative care, the situation and everything around this, 
you don’t have room to reflect calmly, like, “How was the patient doing, what was 
the interaction, and can there be a depressive undertone?” (FP D, FG 3). 
Needs and Possible Solutions 
The family physicians noted shortcomings in the care for depression in 
patients on a palliative trajectory and indicated they would have liked to 
have more education, especially on identifying depression in palliative care, 
or support from a guideline, or access to questionnaires or criteria to 
distinguish between normal and abnormal depressive feelings. 
Physicians with expertise in palliative care stressed the importance of having 
a routine when it came to the technical and logistical management of this 
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care, to create time for psychosocial care. 
They pointed to the lack of collaboration with other disciplines, and lack of 
insight of those disciplines’ possible contributions. They noted that 
promoting teamwork with family physicians, specialists in hospitals, 
therapists, palliative care or nursing teams, social workers, priests, or imams 
was valuable and might result in more attention to patients’ psychological, 
emotional, social, and spiritual needs. Furthermore, they saw a larger role 
for mental health professionals who are trained to work with palliative care 
patients and their partners; as one physician commented, “I notice that 
there are few places where I can refer my [palliative care] patients to”  FP H, 
FG 2). 
 
Discussion 
The family physicians in this study reported that they were frequently 
confronted with depressive symptoms in their palliative care patients and in 
general felt competent to address this issue. 
In supporting these patients, the physicians heavily relied on cumulative 
knowledge in determining whether patients had normal sadness or 
depression that required an intervention. They acknowledged the difficulty 
of discerning depression from normal sadness and sometimes experienced a 
lack of knowledge, time, and additional support sources, such as specialized 
psychologists. 
To enhance management of depression in palliative care patients, family 
physicians suggested (1) specific attention to the diagnostic process of 
depression in palliative care patients in their professional education, (2) a 
specific and practical guideline for depression in palliative care, (3) a 
psychometric tool to assess depression in palliative care patients and to 
follow up on treatment, (4) the availability of mental health professionals 
trained in palliative care, and (5) enhanced collaboration with other health 
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care professionals. 
The physicians reported that they valued their clinical judgment more than 
questionnaires. Other studies have similarly found that family physicians 
con- sider their practical wisdom and clinical judgment to be more 
important than objective assessments.7 In this context, depression 
instruments can aid in shared decision making and monitoring.26 
Most family physicians did not often explicitly diagnose a depressive 
disorder in palliative care patients. In fact, one physician expressed fear 
about interfering with the process of accepting the end of life by labeling 
sadness as pathologic. These findings contrast with those of an earlier study 
of depressed patients in primary   care in which family physicians 
encouraged patients to view depression as separate from the self and 
normal sadness.27 This difference between studies illustrates the specific 
context of palliative care patients requiring a different approach. A 
disadvantage of a conservative approach to diagnosing depression might be 
that depressed palliative care patients do not receive optimal treatment; 
however, if the supportive and contextual care that family physicians offer is 
adequate for most patients, it might spare many patients unnecessary 
intensive and sometimes harmful treatment. 
Several palliative care guidelines call for proactive screening for and 
treatment of depression in patients with terminal cancer who have a limited 
survival time.28,29 Models for active screening and treatment of mood 
symptoms are often based on the medical model, however, and that model 
does not consider family physicians’ care to be the most adequate approach 
to addressing mood symptoms in palliative care. This situation might explain 
why some family physicians do not actively look for depression in palliative 
care patients, even though they are aware that depressive symptoms are 
quite common in this population. Family physicians seem to be more 
interested in clinical utility than in the validity of the diagnosis of 
depression.30-32 They use a contextual concept of depression, which may 
reflect the patient-centered and context-specific care that is promoted in 
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family practice.33,34 This viewpoint was also reflected in the comments of 
participants who maintained that because of a long-term relationship with 
patients, they were able to determine whether the patient’s behavior was 
consistent with the pattern they would expect in the expression of normal 
sadness or whether it was consistent with pathologic sadness. 
From the perspective of patient-centered care, it might prove helpful if 
family physicians spoke openly with their patients and caregivers about how 
to relate to sadness in the process of facing terminal illness in the patients’ 
unique situation. Family physicians could inform their palliative care patients 
that depression is sometimes difficult to assess in the context of a palliative 
trajectory and that it needs monitoring. 
Patients and caregivers could be encouraged to express how they value their 
sadness and whether they feel their sadness is normal or abnormal. 
Furthermore, the physicians should discuss with the patient and caregivers 
treatment options for depression, and both possible benefits and burdens in 
relation to the specific context of the patient. Practical advice for both 
patient and caregivers (such as seeking distraction and pleasant activities, 
approaching the patient not only in the patient role) can also be important. 
To our knowledge, this is the first study to explore how family physicians 
address depression in palliative care. We used a purposive sampling strategy 
to reach an optimal variety of opinions. The limited number of physicians 
may limit extrapolation of the results to all family physicians but is 
considered adequate for a first in-depth exploration.35 Although the study 
reflects the Dutch primary care context, we are confident that our findings 
are valuable more generally: first and foremost, the importance of palliative 
care, in or as close as possible to the patient’s own environment, is a value 
shared by family physicians from many countries. In delivering care, the 
physicians in this study referred to their professional relationship with 
patients and their use of knowledge of patients and their family 
accumulated over time, which are core values of international primary 
care.36 
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In focus group discussions, participants influence each other; therefore, 
contrasting opinions and results may be silenced.35 In this study, however, 
we found that all participants seemed to share their views openly, and we 
obtained a variety of opinions. We included group discussions with 
participants who did not know each other and group discussions with 
established groups in which members might be more used to challenging 
each other’s views and opinions. 
Although the moderator provided a broad working definition of a palliative 
care patient, almost all participants seemed to confine the discussion to 
patients with cancer. In future research, we recommend explicitly including 
in the discussion palliative care patients who do not have cancer. Family 
physicians might have a different approach to depression in this 
population.37 
Two of the researchers who analyzed the data (F.W. and E.vR.) are family 
physicians and familiar with the practice of family medicine, and therefore 
are more likely to interpret the data in the appropriate context. 
Finally, the opinions and experiences that the family physicians expressed 
and described do not provide data about the physicians’ actual behavior and 
the effects on patient outcomes. 
In conclusion, family physicians play a pivotal role in providing patient-
centered and context-specific mental health care for palliative care patients. 
On the basis of the findings of this study, we suggest that family physicians 
acknowledge the importance of the diagnosis and management of 
depression in palliative care and monitor patients’ psychological well-being 
over time. We recommend improving family physicians’ education by 
building on the elements that our study participants presented in diagnosing 
depression and distinguishing it from normal sadness: strengthening 
continuity of care and relationship building with patients and their families, 
throughout the palliative trajectory, and explicitly addressing sadness as 
part of the normal process of coming to terms with the prospect of the end 
of life. Guidelines, criteria, and patient-friendly psychometric tools will 
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provide valuable support only when applicable in the context of such a 
person-centered approach. In this way, family physicians can be supported 
to further improve their approach to the complex situation   of palliative care 
patients facing challenges in nearly all domains (physical, psychological, 
spiritual, and social). This approach acknowledges the importance and use 
of cumulative and contextual knowledge, which is a core quality of family 
practice.38 
Finally, more research is needed to evaluate the actual diagnostic and 
therapeutic processes that family physicians use in managing depression in 
palliative care and the effects on their patients. 
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Chapter 8 
General Discussion 
 
“After prolonged suffering the eyes become dull and lack expression, 
and are often slightly suffused with tears. The eyebrows not rarely 
are rendered oblique, which is due to their inner ends being raised. 
This produces peculiarly-formed wrinkles on the forehead which are 
very different from those of a simple frown; though in some cases a 
frown alone may be present. The corners of the mouth are drawn 
downwards, which is so universally recognized as a sign of being 
out of spirits, that it is almost proverbial.”1 
 
Charles Robert Darwin 1809-1882 
 
The aim of this thesis was to explore depression in palliative care in different 
health care settings. This exploration was not confined only to the presence 
of a specific depressive disorder only in palliative care patients, but also 
explored depression in relation to normal sadness in patients with an 
intractable disease. This final chapter offers a summary and critical appraisal 
of the main findings of the studies performed and presented in this thesis 
and highlights some of the strengths and limitations of this exploration in 
relation to the findings of other research groups. Next, I will discuss the 
main findings concerning my initial research questions presented in chapter 
1: (1) the prevalence of depression in palliative care, (2) the use of screening 
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instruments for depression in palliative care and (3) the patient and 
physicians perspectives on depression in palliative care. Finally, I will 
conclude with discussing how to use the concept of depression in palliative 
care and formulate some relevant recommendations for the clinical practice 
and future research in different palliative care settings. 
 
8.1 Summary of main findings 
In chapter 2 and 3 we explored the question about the incidence and 
prevalence of depression in palliative care patients. Chapter 2 reports about 
a history cohort study, using a 20-year period registration database of 
medical records in four Dutch general practices (Continuous Morbidity 
Registration database) to explore the incidence of a depressive disorder in 
the last phase of life of patients who died from cardiovascular disease, 
cancer or COPD, in a sample of primary care patients. In total 982 patients 
were included of which nineteen patients (1.9%) were diagnosed with a 
depressive disorder in the last year of their life. We concluded that the 
incidence of depressive disorder in the last phase of life as diagnosed in 
actual patient care in a primary care setting, is remarkably lower than 
expected. In chapter 3, we studied the prevalence of depressive disorder by 
performing a structured clinical assessment (SCAN 2.1) in a sample of 64 
advanced cancer outpatients. The main finding of a prevalence of depressive 
disorder in this selected patient group of 3%, confirms a low prevalence of 
depressive disorder in palliative care patients in comparison with the 
prevalence reported by other studies. 
In chapter 4 and 5 we explored the use of screening tools for depression in 
palliative care patients. Chapter 4 reports on the validity of the Beck 
Depression Inventory (BDI-II) and a single screening question as screening 
tools for depression in advanced cancer patients. The mood section of the 
PRIME-MD was used as a gold standard. Complete data were obtained from 
46 patients. The area under the curve of the receiver operating 
characteristics analysis of the BDI-II was 0.82 and the optimal cut-off point 
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of the BDI-II was 16 with a sensitivity of 90% and a specificity of 69%. The 
single screening question showed a sensitivity of 50% and a specificity of 
94%. We concluded that the BDI-II seemed an adequate screening tool for 
depression in advanced cancer patients and that the sensitivity of a single 
screening question is poor. In chapter 5 we explored the relationship 
between scores on screening tools for depression (Beck Depression 
Inventory (BDI-II), Beck Depression Inventory Primary Care (BDI-PC), Hospital 
Anxiety and Depression Scale (HADS)) and different physical symptom 
clusters in a sample of 65 patients. In this study, we found that screening 
instruments for depression correlated highly with different somatic 
symptom clusters. The BDI-II cognitive subscale was the only scale that was 
not significantly correlated with any of the somatic symptom clusters. We 
conclude that screening tools for the detection of depression in patients 
with advanced cancer may not provide an accurate evaluation of depression 
because they may measure physical symptom burden as well, especially 
when patients suffer from symptoms of the clusters fatigue/anorexia/ 
cachexia, neuropsychology, debility, or pain. 
In Chapter 6 we report the findings of an exploration of views of palliative 
care patients on resources and ways of coping that help them prevent or 
manage mood symptoms. We performed a qualitative study through face-
to-face semi-structured interviews with 15 ambulant patients with advanced 
cancer. Patients reported on attitudes and specific coping strategies that are 
helpful, as well as aspects of their life narrative and spirituality. Resources 
were found in meaningful contacts with family and friends and in personal 
attention of professional medical caregivers for their wellbeing. From this 
study, we conclude that palliative care patients can identify resources to 
cope with symptoms of depression in the context of their unique life. We 
suggest that helping patients to identify their personal resources can 
support patient autonomy and patient resilience. 
Finally, in chapter 7 we report about opinions of general practitioners 
regarding the recognition, diagnosis, and management of depression in 
palliative care patients. We conducted four focus group discussions with 22 
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general practitioners. We found that the general practitioners described the 
diagnostic and therapeutic process for depression in palliative care patients 
as continuous and overlapping with the physical, social and existential 
dimensions of palliative care. Differentiating between normal and abnormal 
sadness was viewed as challenging. The general practitioners did not strictly 
apply criteria of depressive disorder but rather relied on their clinical 
judgment and considered patients’ context and background factors very 
important. They indicated that managing depression in palliative care 
patients is mainly supportive and nonspecific. We concluded from this study 
that general practitioners rely on their open communication and a long-
standing physician-patient relationship when diagnosing and managing 
depression in a palliative care patient. They considered the context of their 
patient’s life of great importance. This approach fits in the model of patient-
centered care that is promoted in primary care nowadays. 
 
8.2 Strengths and limitations of this exploration of depression 
in palliative care  
The strength of our studies presented in this thesis is that we studied 
depression from multiple perspectives. We analysed prospective patient 
data from actual patient care in primary care in a validated database of a 
stable patient population in one area of the Netherlands. Furthermore, we 
studied both prevalence and incidence of depression in palliative care 
patients. Next we used both quantitative and qualitative methods and finally 
we considered the opinions on depression of both practitioners and patients 
by analysis of focus group discussions and interviews. 
The limitations of our studies presented in this thesis are the following: 
firstly, recruiting appropriate patients meeting the inclusion criteria for the 
different studies in palliative care research is extremely difficult. Although 
the generalizability of our database study (Chapter 2) is high, several other 
studies in this thesis have rather small samples, limiting the strength of the 
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external validity. Although we made important efforts to include as many 
patients as possible in our study of the prevalence of depression in palliative 
care patients (Chapter 3) and the use of screening tools for depression in 
palliative care patients (Chapter 4 and 5), a considerable drop out during 
these studies has been observed. Possibly, this can result in a selection bias 
since the most deteriorated patients may have dropped out. It was not 
possible to determine whether these patients were also those with more 
depression. Furthermore, participation in research is voluntary and selection 
bias may also have occurred because depressed patients may be less likely 
willing to participate in research. 
Another concern about the external validity is that most of the patients in 
both our quantitative and qualitative studies were oncological patients. We 
cannot automatically extrapolate our results towards palliative patients with 
cardiovascular disease or COPD. 
The recruitment of the general practitioners for the focus group analysis 
may be biased by the fact that general practitioners who are interested and 
active in palliative care settings are more willing to participate in these 
research activities, although we made efforts to include general 
practitioners from a variety of primary care settings and with different levels 
of expertise in palliative care.  
 
8.3 The prevalence and incidence of depression in palliative 
care patients is low 
We have studied both the prevalence and the last-year-of-life incidence of 
depression. Most previous studies about depression in palliative care are 
cross-sectional and thus only report prevalence. In studying the prevalence 
of a depressive disorder in the last phase of life, we have found remarkably 
low numbers in comparison to other research groups. Two systematic 
reviews report a relatively high prevalence of depressive disorder in 
palliative care patients (up to 69%)2,3. However, one of the reviews also 
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reports that the quality of the evidence was poor and that the samples of 
patients were generally small3. Although the other review has been based 
on a literature search, no details were provided of the review methodology 
and the influence of study quality on the outcomes2. Therefore, although 
the findings of the reviews contrast with the findings of our study, we 
consider the low prevalence found in our study a valid result. This finding is 
confirmed by the low incidence of depressive disorder in the last year of life 
that we have found as a valid result from reliable, real life data. 
We have identified four possible factors that may influence the reported 
prevalence and incidence of depression in palliative care patients: the 
method of assessment, the assessor, the patient sample and the context of 
the assessment. 
Firstly, there is no consensus on the method of assessment of depression in 
palliative care patients. It is obvious that the reported prevalence of 
depression is dependent on the method of assessment of depression. 
Previous studies show that the more robust the method, the lower the 
prevalence of depression that is found4. In one of our studies (Chapter 3), 
the reported prevalence of depressive disorder (3%) may indeed have been 
low because the SCAN 2.1 is a robust clinical interview. 
Secondly, the assessor may play an important role in finding a low 
prevalence of depression in palliative care patients. In studying the 
incidence of depression in the last phase of life in the Continuous Morbidity 
Registration (Chapter 2), the assessment was performed by general 
practitioners. As we report in Chapter 7, general practitioners frequently use 
a contextual concept of depression in which they do not strictly follow DSM-
IV criteria for depression and sometimes are even reluctant to diagnose 
depression in the last phase of life. They consider sadness as appropriate in 
the context of palliative care and are primarily concerned with helping the 
patient to improve empowerment without medicalizing normal sadness. 
Possibly, this contributed to the finding of a low incidence of depression in 
the sample of patients that participated in our studies. 
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Thirdly, as reported already in the strengths and limitations section, our 
selected patient sample specifically recruited for the purpose of this 
research on depression may be biased by the inclusion of a sample of 
patients with less depressive complaints since patients with more advanced 
disease are mostly no longer in the capacity of participating in clinical 
studies5. 
Finally, the context in which diagnoses for depression are made could have 
influenced the findings. In the CMR database (Chapter 2), diagnoses of 
depression were made in the context of actual patient needs and in the 
context of the delivered care by primary care physicians. Patients seeking 
for help are different from patients in the general population without an 
explicit reason to seek help, not only in the prevalence of depression, but 
also in their expectations for support6. In primary care, the diagnostic 
process for depression is not explicitly focussed on depressive disorder as 
defined by the DSM IV criteria; diagnoses are made in the context of 
patients needs in contrast with population research.  
Notwithstanding the findings in these studies that the prevalence and 
incidence of depression in palliative care patients is low, this does not imply 
that there is no patient need for care for mood symptoms, even in patients 
who are not diagnosed with depression. For future research, it might be 
helpful to focus on patients’ needs along with specific disease characteristics 
to improve the analysis of the prevalence. Consequently, our knowledge 
about patients’ needs to support their depressive complaints will improve 
and can result in better patient care. 
 
8.4 A limited use for screening instruments for depression in 
palliative care patients 
In clinical practice, a screening tool supports physicians to better identify 
possible depressions in their patients. Hence, a better attention and focus 
will be given to the mental health status of palliative care patients, resulting 
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in better assessments and appropriate treatment and support for the 
depressed patient in a palliative trajectory7. Most screening instruments are 
presented with psychometric values (such as sensitivity and specificity) that 
give an indication about the validity of a screening instrument. In our study 
of the BDI-II (Chapter 4) we conclude that the BDI-II seems to be an 
adequate screening tool to detect a depressive disorder in patients in a 
palliative trajectory because it has a high sensitivity (90%) and adequate 
specificity (69%). 
However, when using screening instruments for depression in palliative care 
patients we should use appropriate measurement instruments that are 
specifically developed for the detection of the problem we want to observe, 
limiting the false positive or false negative results. If the prevalence of a 
depressive disorder is indeed much lower than previously assumed, we will 
detect more false positives with the specific screening instrument resulting 
in unnecessary medicalization of many cases without a real depressive 
disorder. Those false positive cases may be caused by feelings of normal 
sadness that are very common in a palliative care context. 
Because of the low prevalence of depressive disorder and the test 
characteristics of the available screening instruments, we propose not to 
screen for depressive disorder in palliative patients in primary care. Instead, 
we advocate a person-centered approach with specific attention for 
emotional symptoms. 
 
8.5 Different perspectives on depression in palliative care: 
bridging the gap between the assessment of depression and the 
experience of the patient 
From our qualitative interview study (Chapter 6), we conclude that palliative 
care patients can identify positive resources to cope with their symptoms of 
depression in the context of their own life situation. Previous research in 
general practice confirms that patients are able to identify personal health 
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resources and it is suggested that general practitioners (GPs) should help 
patients to identify and mobilize those resources within the unique context 
of each individual patient8. This offers a new opportunity for the 
management of depression in palliative care patients. As reported by the 
focus group study (Chapter 7), GPs try to optimize their support to palliative 
care patients to minimize suffering and increase well being in the context of 
each patient’s unique life. While doing this, GPs do not rely on a specific 
disease model in the care for their palliative care patients. This attitude fits 
with the perspective of their patients who experience symptoms in the 
context of facing the loss of their physical health, independency, social role, 
of friends and family and eventually the loss of life itself. 
Professional caregivers who do use the disease model to relate to feelings of 
sadness may be more inclined to look at the content of symptoms with the 
purpose to make a diagnosis and subsequently offer an intervention. They 
primarily use their professional expertise. In contrast, professional 
caregivers who consider symptoms in the context of what is happening in a 
person’s life will be more inclined to take into account the personal 
experience of the patient9-11. They use their personal relationship with the 
patient to clarify, in a communal process with their patient, the optimal 
strategy or intervention. We feel that the latter model is more appropriate 
for the management of emotional symptoms in palliative care patients, 
partly because this model is more in agreement with what patients think 
and experience, partly because there are several concerns about the disease 
model, as exemplified by the DSM model12-15. Those concerns may be even 
greater in the palliative care context. Firstly, especially in the palliative care, 
it can be challenging, if not impossible, to determine accurately whether 
sadness experienced by a palliative care patient is a normal reaction in 
relation to the stressful situation of facing a terminal illness, or whether the 
sadness is a symptom of a disease. Secondly, sadness as perceived by 
physicians, may change over time, in different cultures. Changes in 
perspectives on depression in palliative care may result in an emphasis on 
either the concern for overmedicalization and overtreatment of normal 
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sadness or the under diagnosis of depressive disorder in palliative care 
patients16-17. Moreover, the perspective of health care givers influences the 
interpretation of a supposedly clear and objective definition such as a 
depressive disorder. 
 
8.6 Normal sadness and depression in the practice of integral 
palliative care 
In giving direction to the assessment of depression in palliative care patients 
in line with the more multidimensional concept of depression proposed in 
the previous paragraph, we recommend that health care professionals 
should consider to use case formulation when assessing emotional issues, 
instead of assessing a depressive disorder. We argue that if we direct our 
attention on the assessment of depression this may cause many false 
positive cases of depressive disorder, thereby medicalizing normal sadness 
and possibly even resulting in a lack of attention for normal sadness. Many 
palliative care patients without a depressive disorder or depression may 
benefit from professional emotional support for their normal sadness. 
Case formulations – as a manifestation of person-centred care - are used in 
situations when there are no discrete entities with natural boundaries that 
separate them from other disorders or problems. This method comprises a 
multidimensional inventory of problems and needs and the formulation of 
the presenting problem, the predisposing factors, precipitating factors, the 
perpetuating factors, protective factors and positive factors all related to 
the context of emotional aspects experience by a palliative care patient18. 
We argue that in a palliative care context, a case formulation offers a more 
accurate and useful representation that may also bridge the gap between 
assessment and treatment. Furthermore, it can give direction in both 
attending to the problems as well as to positive factors and thus help us to 
provide integral palliative care. 
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According to the WHO definition of palliative care, palliative care affirms life, 
while regarding dying as a normal process. This normal process in an 
individual patient can be accompanied by sadness, anxiety and other 
symptoms, but also with other factors such as vitality, humour, hope, 
courage, friendships and many more expressions of positive qualities. We 
advocate that in integral multidimensional palliative care we should improve 
inconvenient symptoms and at the same time provide support to strengthen 
resources. 
In the last decades, increasing attention is given to preventive medicine and 
the advertisement of healthy behaviour19. In this model of thinking about 
health care, the distinction between ‘normal’ and ‘abnormal’ becomes less 
important. From the idea that every person will face adversity in his life and 
not all suffering can be prevented, the model of salutogenesis is used 
instead of pathogenesis in order to identify resources and increase resilience 
against adversity20. This seems to be an approach that can be adapted to the 
complex context of palliative care when it may not be possible to alleviate 
all symptoms and in which the outcome will certainly be death. One could 
argue that in palliative care we should focus most on optimally alleviating all 
symptoms to allow the patient to live his life without symptoms. But even if 
we could alleviate all symptoms until the patient dies, one could also argue 
that life may be more than just living without symptoms. Instead of almost 
exclusively focusing our palliative care on the alleviation of symptoms, we 
could also ask our patients: What does your life stand for? What do you still 
want with your life? How can we support you in this? We would move from 
a model of disease and symptoms, to a model of what it means to live in a 
valuable way until one dies. In this person-oriented care the relationship 
between patient and caregiver is important in openly exploring what would 
be a valuable way for patients to live their remaining lifetime. This view is 
not a denial of disease and symptoms, but an integration of both positive 
and negative in finding the optimal balance for valued living. 
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8.7 Main conclusions and recommendations 
The title of this thesis indicates a distinction between normal sadness and 
depression in palliative care. Firstly, we conclude that the ambiguous use of 
the terminology of depression and sadness in palliative care both in clinical 
practice and research causes much obscurity. An applicable, definitive 
definition of depression in palliative care and its distinction from normal 
sadness is not available, mainly because it is dependent on many personal 
and context-related factors. Therefore, we recommend that both 
researchers and clinicians explicitly define the concept of depression that is 
used in their clinical practice and research. 
Furthermore, from our exploration of depression in palliative care, we 
conclude that depression is not a common disease in palliative care patients 
and that if we aim for the assessment of depression in palliative care 
patients, we will medicalize cases of normal sadness into disorder. Recently 
a guideline has been developed by the European Association of Palliative 
Care to inform practice, establish policy and promote European consensus 
around depression in palliative care patients21. Although we agree with 
many of the recommendations in this guideline on the prevention of 
depression in palliative care, we disagree with the specific focus on 
diagnosing depressive disorder with a psychiatric assessment. We 
recommend that in palliative care emotional issues are addressed and 
sadness is explicitly identified as part of the normal process of coming to 
terms with the prospect of the end of life. We recommend a context-
related, patient-centred approach for both normal sadness and depression 
in palliative care patients in a multidisciplinary team.  
Furthermore, we recommend using case formulation when assessing 
emotional issues in palliative care patients, in contrary to the assessment of 
a possible depressive disorder. A case formulation may bridge the gap 
between assessment and treatment and can give direction in both attending 
to the problems as well as to positive factors and thus help us to provide 
integral palliative care. Moreover, we recommend discussing emotional 
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issues with palliative care patients in an open communication that addresses 
both the symptoms as well as the factors that may increase resilience, 
thereby preventing depressive disorder. 
Specifically for general practice we recommend general practitioners to 
strengthen their continuity of care and relation building with palliative care 
patients and their families, throughout the palliative trajectory. Finally, we 
recommend more research on specific interventions that can increase 
resilience in the end of life phase, such as dignity therapy 22, narrative 
therapy 23 and other psychological interventions. 
In palliative care there seems to be agreement on the importance of using a 
holistic, integral model of palliative care to address the different dimensions 
of physical, psychological, social and spiritual care. Within this model, 
however, there is always the individual patient to attend to. Whatever 
dimension we are addressing, a key element seems to be to connect to the 
individual patient and his or her context. This is essential in the communal 
process that we go through together with our patient, navigating through 
the complexity of physical, psychological, social and spiritual issues that can 
all be interrelated. The model of different dimensions of palliative care can 
be our nautical chart, and a very helpful one, but the actual sailing we have 
to do together with our patient.  
The same may be true when addressing symptoms of depression in a 
palliative care context. Some of the general practitioners in our study 
(Chapter 7) explicitly reported using models, guidelines and screening tools 
for depression. They also recognized however that these instruments are 
limited when it comes to making an assessment in the individual context of 
the patient. Sometimes they feel it is appropriate, based on their 
‘cumulative knowledge’ and their actual connection with the patient, to 
classify symptoms of mood as ‘normal sadness’ for which they will also 
provide care and attention. Assessing depression in palliative care remains a 
challenge, but being aware of the available models and screening tools and 
interpret them in the context of the individual patient may do justice to the 
high-quality patient-centred care that we are aiming for. Furthermore, 
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working in a multidisciplinary team, in which each professional brings his 
expertise, it is important that we communicate about the way we navigate 
as a team, together with the patient. If we all can bring our expertise and 
orient our care as a team within the context of the individual, the patient 
might benefit the most. 
The challenge of health care and health care education is to allow models, 
protocols and frameworks to help us orient theoretically and, when bringing 
this knowledge into the context of the patient, to remain aware that the 
patient is the true reference point of our care. 
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Epilogue 
 
“It is not possible to leave death to the dying.” 
 
Irving Yalom, Existential Psychotherapy 
 
This thesis started with surprise and it will end with surprise. Surprise can be 
a powerful pointer: it can disclose our expectations and convictions, even 
those of which we are not aware. When we give surprise some space, it can 
help us to start questioning and it can offer us the openness to look from a 
different perspective than we are used to. 
Personally, I have been surprised by many of the patients that I have met in 
this research project. Mainly, I have been surprised by their courage and 
their willingness to share with a curious stranger what they knew about 
being sad and being happy in the context of the end of their life. I have also 
been surprised by the resilience of many patients to what seems sometimes 
intolerable or unbearable. During my exploration of depression in palliative 
care, it was my intention to always remain connected to the perspective of 
the patient as a true reference point of my search. Sometimes the methods 
of science seemed to distract me from this reference point and in my 
experience this created some rigidity in the exploration. I did not always find 
it easy to hold the balance between science and the connection with 
another human being. With this thesis, I hope I have done justice to both 
the patients and science. I would like to end this thesis with a few personal 
observations that I have found valuable. 
Depression in palliative care: Normal sadness or disorder? 
146 
 
Living and caring in the light of death 
In his book Existential Psychotherapy, Irving Yalom writes that it is not 
possible to leave death to the dying. Not only does dying sometimes happen 
in our presence and do we have a personal (and for health caregivers a 
professional) obligation to relate to dying and to care for the dying, but also 
our own mortality frequently compels us to actively relate to dying. 
Although the moment of death seems to be a very precise and well-defined 
event and although many of us are only occasionally aware of the presence 
of death in our lives, death continuously accompanies our lives 
psychologically. From this perspective, life and death exist simultaneously, 
not consecutively. Awareness of impermanence forms an important and 
valuable therapeutic starting point and potential for change in the 
existential psychotherapy of Irving Yalom. Especially when working with 
palliative care patients it is inevitable that we are frequently confronted 
with impermanence and also our own mortality. If we shy away from this 
confrontation, this will most likely influence the relationship that we have 
with our patients and possibly disable us to optimally connect and deliver 
well-attuned care for our patient. However, if we allow the experience of 
relating to our own dying to be a potential for change, we may find the 
richness and personal growth that many people who work in palliative care 
experience. In one of the interviews for this thesis, a patient explained to 
me how he thought that relating to his own dying was not such a difficult 
thing, simply because it was not a surprise. He had been aware of his 
mortality most of his life and had already accepted that dying would be part 
of his life. Working in palliative care invites us to bring our whole selves to 
the experience and may offer us the possibility to embrace dying and at the 
same time value our lives and live fully. 
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The importance of connection 
In my exploration during this research, I have found that my connection with 
the patient was primary to all other objects and goals I may have had. If 
there was no connection, there was no common ground from which to 
explore and question. When the connection from my side was clouded by a 
goal-oriented attitude, the meeting with the patient and the experience 
shared by the patient were often shallow and superficial. In contrast, the 
meetings when I felt I did not know exactly what to say or what to do, and 
only tried to be present with the patient and what was arising, were often 
the richest both in the shared information as well as in the felt connection. 
A caregiver-patient relationship may also sometimes be clouded by 
identification with roles and a goal-oriented attitude. The caregiver may be 
occupied with categorizing symptoms, registering diagnosis and following 
guidelines and protocols. However, the first thing that happens when a 
caregiver meets a patient is that a human being meets another human 
being. If we can value the nakedness of this meeting and dare to stand in 
this essence of connection, we may find that this connection facilitates and 
enriches our work. It may even be that this connection is the medium where 
most of our healing, also when it comes to complaints of sadness or 
depression, takes place. 
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Summary 
This thesis explores depression in palliative care patients. The prologue 
illustrates the origin of my personal interest in this subject. 
Chapter 1 gives a general introduction to the subject of depression in 
palliative care and provides the research objectives and outline of the thesis. 
Firstly, it illustrates the context of palliative care and secondly, it highlights 
the complexity of depression in a palliative care context and the relevance 
of right understanding and correct management of depression in palliative 
care. Furthermore it explicitly focuses on the problems that are encountered 
around this subject: applying the definition of depression in a palliative care 
context, differentiating between depression and normal sadness and the 
use of screening instruments for depression in a palliative care context. 
Finally, Chapter 1 concludes with the research objectives and an outline of 
the thesis in the following chapters. 
Chapter 2 reports about a historic cohort study, using a 20-year period 
registration database of medical records in four Dutch general practices 
(Continuous Morbidity Registration database) to explore the incidence of 
depressive disorder in the last phase of life of patients who died from 
cardiovascular disease, cancer or COPD, in a sample of primary care 
patients. The data were derived from actual patient care in general practice 
where diagnoses were made by general practitioners in the context of 
patient needs and the delivered care. In total 982 patients were included. 
Nineteen patients (1.9%) were diagnosed with a depressive disorder in the 
last year of their life. We concluded that the incidence of depressive 
disorder in the last phase of life is remarkably lower than expected. 
In Chapter 3 we studied the prevalence of depressive disorder by 
performing a structured clinical assessment (SCAN 2.1) in a sample of 64 
advanced cancer outpatients. In finding a prevalence of depressive disorder 
of 3% in our patient sample, we concluded that there is a low prevalence of 
depressive disorder in advanced cancer patients. 
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Chapter 4 reports on the validity of the Beck Depression Inventory (BDI-II) 
and a single screening question as screening tools for depressive disorder in 
advanced cancer patients. Patients with advanced metastatic disease, 
visiting the outpatient palliative care department, were asked to fill out a 
self-questionnaire containing the Beck Depression Inventory (BDI-II) and a 
single screening question “Are you feeling depressed?” The mood section of 
the PRIME-MD was used as a gold standard. Sixty-one patients with 
advanced metastatic disease were eligible to be included in the study and 
complete data were obtained from 46 patients. The area under the curve of 
the receiver operating characteristics analysis of the BDI-II was 0.82. The 
optimal cut-off point of the BDI-II was 16 with a sensitivity of 90% and a 
specificity of 69%. The single screening question showed a sensitivity of 50% 
and a specificity of 94%. We concluded that the BDI-II seemed an adequate 
screening tool for a depressive disorder in advanced cancer patients and 
that the sensitivity of a single screening question is poor. 
In Chapter 5 we explored the relationship between physical symptom 
burden and psychological distress in palliative care patients in relation to 
scores on screening instruments for depression. In a sample of 65 patients, 
we explored the relationship between scores on screening tools for 
depression (Beck Depression Inventory (BDI-II), Beck Depression Inventory 
Primary Care (BDI-PC), Hospital Anxiety and Depression Scale (HADS)) and 
different physical symptom clusters. The physical symptoms were assessed 
with the Memorial Symptom Assessment Scale Short Form (MSAS-SF). In 
this study, we found that screening instruments for depression correlated 
highly with different somatic symptom clusters. The BDI-II cognitive subscale 
was the only scale that was not significantly correlated with any of the 
somatic symptom clusters. We conclude that screening tools for the 
detection of depression in patients with advanced cancer may not provide 
an accurate evaluation of depression because they may measure physical 
symptom burden as well, especially when patients suffer from symptoms of 
the clusters fatigue/anorexia/ cachexia, neuropsychology, debility, or pain. 
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The BDI-II cognitive subscale seemed to differentiate best from somatic 
symptom burden. 
In Chapter 6 we report on an exploration of views of palliative care patients 
on resources and ways of coping that help them prevent or manage mood 
symptoms. We performed a qualitative study through face-to-face semi-
structured interviews with fifteen ambulant patients with advanced cancer. 
The interviews were transcribed verbatim and qualitative analysis was 
independently performed by two researchers, according to the principle of 
constant comparative analysis. Patients reported on attitudes and specific 
coping strategies that they found helpful, as well as aspects of their life 
narrative and spirituality. Resources were found in meaningful contacts with 
family and friends and in personal attention of professional medical 
caregivers for their wellbeing. From this study, we conclude that palliative 
care patients can identify resources to cope with symptoms of depression in 
the context of their unique life and we suggest that in helping patients to 
identify the personal resources that are accessible and available in their 
specific context, patient autonomy in enhancing resilience can be increased. 
Chapter 7 reports about opinions of general practitioners regarding the 
recognition, diagnosis, and management of depression in palliative care 
patients. We conducted four focus group discussions in a sample of twenty-
two general practitioners with varied practice locations and varying 
expertise in palliative care. Transcripts were analyzed independently by 2 
researchers using constant comparative analysis in ATLAS.ti. We found that 
the general practitioners described the diagnostic and therapeutic process 
for depression in palliative   care patients as a continuous and overlapping 
process. Differentiating between normal and abnormal sadness was viewed 
as challenging. The general practitioners did   not strictly apply criteria of 
depressive disorder but rather relied on their clinical judgment and strongly 
considered patients’ context and background factors. They indicated that 
managing depression in palliative care patients is mainly supportive and 
nonspecific. Antidepressant drugs were seldom prescribed. The general 
practitioners also described difficulties in diagnosing and treating depression 
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in palliative care, and we report their suggestions to improve management 
of depression in palliative care patients in primary care. We conclude from 
this study that general practitioners rely on open communication and a long-
standing physician-patient relationship when diagnosing and managing 
depression in a palliative care patient. They view the patient’s context of 
great importance. This approach fits with the patient-centered care that is 
promoted in primary care. 
Finally, in Chapter 8 we discuss our findings in a more general way. First we 
provide a summary of our main findings and highlight some of the strengths 
and limitations of our exploration. Furthermore, we discuss the findings in 
relation to the initial research objectives concerning the prevalence and 
incidence of depression in palliative care, the use of screening instruments 
for depression in palliative care and the patient and physicians perspectives 
on depression in palliative care. Also in this chapter some recommendations 
are made for the clinical practice and for future research in depression in 
palliative care. 
In the epilogue, finally, I give my personal view about the value of living and 
caring in the light of death and the importance of connection. 
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Samenvatting 
Dit proefschrift gaat over depressie bij palliatieve patiënten. In de proloog 
schets ik de oorsprong van mijn persoonlijke interesse in dit onderwerp. 
Hoofdstuk 1 geeft een algemene introductie over depressie in de palliatieve 
zorg en beschrijft de vraagstellingen en de opzet van dit proefschrift. 
Allereerst wordt de context van de palliatieve zorg geschetst en daarnaast 
wordt de complexiteit van depressie in de context van de palliatieve zorg 
geïllustreerd en de relevantie van een goed begrip van dit onderwerp om 
goede zorg te kunnen bieden voor patiënten met depressie in de palliatieve 
fase. Verder worden in hoofdstuk 1 de problemen die er rond dit onderwerp 
bestaan beschreven: het toepassen van de definitie van depressie in de 
context van de palliatieve patiënt, het onderscheiden van depressie van 
normaal verdriet en het gebruik van screeningsinstrumenten voor depressie 
in de context van de palliatieve zorg. Tot slot worden de onderzoeksvragen 
van dit proefschrift geformuleerd en wordt de opbouw van het proefschrift 
beschreven. 
In hoofdstuk 2 worden de bevindingen van een historisch cohortonderzoek 
gepresenteerd. Hiervoor is een periode van 20 jaar van de Continue 
Morbiditeits Registratie (CMR database) in vier huisartspraktijken gebruikt 
waarbij gekeken is naar de incidentie van depressieve stoornis in de laatste 
fase van het leven van patiënten in de eerstelijns zorg die overleden zijn aan 
hartvaatziekten, kanker of COPD. De data van dit onderzoek is gebaseerd op 
de reële patiëntenzorg in de huisartspraktijk waarbij diagnoses werden 
gesteld door huisartsen in de context van zorg, verleend vanuit de actuele 
behoeften en hulpvraag van patiënten. In totaal zijn 982 patiënten in deze 
studie geïncludeerd waarvan er 19 (1,9%) in het laatste jaar van het leven 
gediagnosticeerd werden met een depressieve stoornis. De conclusie van dit 
onderzoek is dat de incidentie van depressieve stoornis in de laatste fase 
van het leven opvallend lager is dan verwacht. 
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In hoofdstuk 3 hebben we de prevalentie van depressieve stoornis in een 
steekproef van 64 poliklinische patiënten met een vergevorderd stadium 
van kanker bepaald door een diagnostisch psychiatrisch interview (SCAN 
2.1) af te nemen. De prevalentie van depressieve stoornis in de steekproef 
was drie procent. De conclusie van dit onderzoek is dat de prevalentie van 
depressieve stoornis in patiënten met een vergevorderd stadium van kanker 
laag is.  
Hoofdstuk 4 beschrijft de validiteit van de Beck Depression Inventory (BDI-II) 
en een enkelvoudige screeningsvraag als screeningsinstrumenten voor 
depressieve stoornis in patiënten met een vergevorderd stadium van 
kanker. Patiënten met een gemetastaseerde oncologische aandoening werd 
gevraagd om een vragenlijst in te vullen waaronder de Beck Depression 
Inventory (BDI-II  en een enkelvoudige screeningsvraag ‘Voelt u zich 
depressief?’. De sectie depressie van de P IME-MD werd gebruikt als 
gouden standaard. Van 46 patiënten werd volledige data verzameld. De 
oppervlakte onder de curve (AUC) van de receiver operating characteristics 
(ROC) analyse van de BDI-II was 0,82. Het optimale afkappunt van de BDI-II 
was 16 resulterend in een sensitiviteit van 90% en een specificiteit van 69%. 
De enkelvoudige screeningsvraag resulteerde in een sensitiviteit van 50% en 
een specificiteit van 94%. We concludeerden dat de BDI-II een adequaat 
screeningsinstrument voor depressieve stoornis kan zijn bij patiënten met 
een vergevorderd stadium van kanker en dat de sensitiviteit van de 
enkelvoudige screeningsvraag slecht is. 
In hoofdstuk 5 hebben we het verband tussen fysieke symptoomlast en 
psychologische symptoomlast onderzocht. Hiervoor hebben we in een 
steekproef van 65 palliatieve patiënten de relatie tussen scores op 
screeningsinstrumenten voor depressie (Beck Depression Inventory (BDI-II), 
Beck Depression Inventory Primary Care (BDI-PC), Hospital Anxiety and 
Depression Scale (HADS)) en verschillende fysieke symptoomclusters 
onderzocht. De fysieke symptomen werden beoordeeld met de Memorial 
Symptom Assessment Scale Short Form (MSAS-SF). In deze studie vonden 
we dat screeningsinstrumenten voor depressie hoog correleren met 
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verschillende fysieke symptoomclusters. De BDI-II cognitieve subschaal was 
de enige schaal die niet significant gecorreleerd was met de fysieke 
symptoomclusters. We concludeerden uit deze studie dat 
screeningsinstrumenten voor het opsporen van depressie bij patiënten met 
een vergevorderd stadium van kanker mogelijk geen accurate weergave van 
het voorkomen van depressie geeft omdat de screeningsinstrumenten ook 
fysieke symptoomlast meten, vooral als patiënten symptomen hebben uit 
de clusters vermoeidheid/anorexia/cachexie, neuropsychologische 
symptomen, fysieke beperkingen of pijn. De BDI-II cognitieve subschaal 
differentieert het beste van de fysieke symptoomlast. 
In hoofdstuk 6 beschrijven we een exploratie van opvattingen van 
palliatieve patiënten over krachtbronnen en manieren van voorkomen en 
omgaan met klachten van somberheid. Hiervoor hebben we een 
kwalitatieve studie uitgevoerd met semigestructureerde interviews bij 
vijftien ambulante patiënten met een vergevorderd stadium van kanker. De 
interviews werden uitgeschreven en door twee onderzoekers onafhankelijk 
geanalyseerd volgens het principe van de continue vergelijkende analyse. 
Patiënten in dit onderzoek rapporteerden over attitudes en specifieke 
coping strategieën die zij behulpzaam vonden. Daarnaast gaven zij 
krachtbronnen aan vanuit hun levensverhaal en de beleving van 
spiritualiteit. Krachtbronnen werden ook gevonden in betekenisvolle 
contacten met familie en vrienden en in persoonlijke aandacht van 
professionele zorgverleners. Op basis van de bevindingen in deze studie 
concludeerden we dat palliatieve patiënten krachtbronnen kunnen 
benoemen om klachten van somberheid te voorkomen en het hoofd te 
bieden. We geven de suggestie dat zorgverleners palliatieve patiënten 
kunnen helpen om hun persoonlijke krachtbronnen te identificeren die 
toegankelijk en beschikbaar zijn in hun specifieke context, waardoor de 
autonomie van patiënten toe kan nemen. 
Hoofdstuk 7 beschrijft opvattingen van huisartsen ten aanzien van het 
herkennen, diagnosticeren, behandelen en/of begeleiden van depressie bij 
palliatieve patiënten. We hebben hiertoe vier focusgroep discussies 
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uitgevoerd met tweeëntwintig huisartsen uit verschillende 
huisartspraktijken en met verschillende expertiseniveaus in palliatieve zorg. 
Na het uitschrijven van de discussies werden de transcripten door twee 
onderzoekers onafhankelijk geanalyseerd met gebruik van continue 
vergelijkende analyse. De bevindingen waren dat huisartsen het herkennen, 
diagnosticeren en begeleiden of behandelen van depressie bij palliatieve 
patiënten als een continu proces ervaren. Het maken van het onderscheid 
tussen normaal en pathologische verdriet werd als moeilijk ervaren. De 
huisartsen gebruikten geen strikte toepassing van de criteria voor 
depressieve stoornis, maar vertrouwen sterk op hun klinisch oordeel waarbij 
ze de context van de patiënt en achtergrondfactoren sterk lieten 
meewegen. Ze gaven verder aan dat de begeleiding en behandeling van 
depressie bij palliatieve patiënten voornamelijk ondersteunend en niet 
specifiek is. Antidepressiva werden zelden voorgeschreven. De huisartsen 
beschreven verder moeilijkheden in het diagnosticeren en behandelen van 
depressie bij palliatieve patiënten en in hoofdstuk 7 beschrijven wij hun 
suggesties om de zorg voor depressie bij palliatieve patiënten in de 
eerstelijn te verbeteren. De context van de patiënt speelt voor de huisartsen 
een cruciale rol in het omgaan met depressie bij palliatieve patiënten. Dit 
past in het zorgmodel dat vaak in de huisartspraktijk toegepast wordt en 
waarin de patiënt centraal staat. 
Tot slot wordt in hoofdstuk 8 een overzicht gegeven van de belangrijkste 
bevindingen uit de voorgaande hoofdstukken en worden sterke en zwakke 
punten van dit onderzoek beschouwd. Daarna bespreken we de 
belangrijkste onderzoeksbevindingen in relatie tot de onderzoeksvragen van 
dit proefschrift over de prevalentie en incidentie van depressie in de 
palliatieve fase, het gebruik van screeningsinstrumenten voor depressie in 
de palliatieve zorg en verschillende perspectieven op depressie in de 
palliatieve zorg. Hoofdstuk 8 sluit af met aanbevelingen voor de klinische 
praktijk en onderzoek. 
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In de epiloog geef ik tenslotte mijn persoonlijke visie over de waarde van 
leven en zorgen in het licht van het sterven en het belang van verbinding 
hierin. 
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Dankwoord 
 
“When one tugs at a single thing in nature, 
he finds it attached to the rest of the world.” 
 
John Muir (1838 - 1914) 
 
Een grote klus kun je niet alleen klaren….. Er zijn veel mensen met wie ik mij 
verbonden voel  en ik ben velen dankbaar voor de steun die ik heb mogen 
ontvangen in het schrijven van dit proefschrift. 
Allereerst zijn er de patiënten met wie dit verhaal begonnen is. De 
verwondering en het respect dat ik voor hen voel, heeft aan de wieg gestaan 
van het werk van de afgelopen jaren. In veel huizen ben ik gastvrij 
ontvangen en de openhartigheid waarmee mensen hun verhaal deelden, 
heeft mij diep geraakt. Niet zelden stapte ik geroerd en met tranen in mijn 
ogen de auto weer in. 
Zonder de onafgebroken en kundige begeleiding van promotoren Kris 
Vissers, Chris van Weel en Judith Prins en van copromotor Peter Lucassen 
zou het niet gelukt zijn om alle informatie en ervaringen die ik verzameld 
heb in het licht van de wetenschap te zetten. De weg is niet zonder hobbels 
geweest. Het stoeien met nieuwe concepten en ideeën kan schijnbare 
zekerheden onderuit halen en vraagt daarom een zekere moed en 
openheid. Ik dank jullie allen dat jullie daartoe bereid waren en dat jullie mij 
hierin uitgedaagd en ondersteund hebben.  Peter, speciaal dank voor de 
momenten waarop je voorstelde ‘even een rondje te gaan lopen’. De frisse 
lucht deed mij goed…… 
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Eric, ook jou ben ik veel dank verschuldigd. De eerste jaren van het 
onderzoek ben je mijn directe sparring partner geweest. Onze gedeelde visie 
op patiëntenzorg heeft de richting van mijn onderzoek wezenlijk bepaald en 
ik ben je dankbaar dat je me gestimuleerd hebt om de impulsen vanuit die 
visie te volgen. 
Bregje en Marieke, de tijd dat wij samen op de Buitenhoek werkten, is wat 
mij betreft te kort geweest. Ik dank jullie voor jullie vriendschap, jullie 
openheid en het verdragen van hondenluchtjes en natte neuzen…...  ok de 
andere collega’s op de Buitenhoek en op de Omloop, en in het bijzonder 
Yvonne, Kathrin en Jeroen, wil ik hartelijk bedanken voor de collegialiteit, 
het meedenken, het meevieren en het meeleven. 
Het palliatieve team heeft de eerste jaren hard meegewerkt aan het 
rekruteren van patiënten en hiervoor wil ik met name Jose, Henny, Jeroen 
en Stans bedanken. 
Mijn Leuvense collega’s Mieke, Wouter, Jan en Bert, dank ik voor de zeer 
aangename en moeiteloze samenwerking en de mogelijkheid om samen te 
kunnen dromen over nieuw onderzoek op het gebied van spiritualiteit in de 
palliatieve fase. Ik hoop dat we dit jaar en de daarop volgende jaren veel van 
deze dromen mogen verwezenlijken. 
Mijn paranifmen, Carolien en Bregje, dank voor jullie steun. Ik voel jullie 
achter en naast me staan. Alle aanmoediging en de nodige relativering kon 
en kan ik goed gebruiken! 
Rob Vincken wil ik bedanken voor het eindeloos openen voor nieuwe 
perspectieven in mijn werk en in mijn leven. Ondanks alle botsingen ervaar 
ik een groot vertrouwen in onze verbinding en de grenzeloosheid in jouw 
creativiteit stel ik erg op prijs. Hugo Alberts wil ik bedanken als een dierbare 
onafhankelijke sparring partner. In Coffeelovers worden mooie ideeën 
geboren…..ik kijk uit naar de toekomst. Carlein Karimoen, dankjewel voor 
onze gesprekken over het leven. Het helpt mij om zowel het leven als het 
sterven beter te begrijpen. Jean, Johanna en Sjengske, dank voor jullie 
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vriendschap en aanwezigheid. Ik hoop nog veel met jullie te mogen zijn, 
bewegen en beleven. Hakim, dank voor al die kopjes thee. Ik hoop er nog 
veel te mogen drinken! 
Ik wil op deze plaats ook een diepe buiging maken naar mijn leraren zonder 
wie ik niet zou zijn wie ik nu ben: Jos Vanroy, Philippe Voarino, Patrick 
Cassidy, Miles Kessler, Ad van Dun en anderen die ik niet allemaal bij naam 
kan noemen. Jullie leerden en leren mij mezelf en de wereld kennen. 
Hetzelfde geldt voor allen die ik regelmatig op de aikidomat tref en met wie 
ik het voorrecht heb om te oefenen en te exploreren. Ik voel me thuis bij 
jullie. 
Ik wil Marry en Lex bedanken voor de gastvrijheid om hun huis voor mij 
open te stellen in de eerste jaren van mijn werk in Nijmegen. Het ‘thuis’ 
komen terwijl het eten net op tafel gezet werd, was voor mij een ongekend 
genoegen! Mijn moeder, Jonet, dank ik voor de moed die zij heeft om 
ondanks alles haar eigen weg te gaan. Ik dank Inge voor de niet aflatende 
bereidheid om te kijken naar de intermenselijke relaties in de 
wetenschappelijke wereld en Jordi en Anna voor de stevige connectie met 
de noordelijke gebieden. In jullie jongens, Theo en Max, zie ik iedere keer 
weer het bruisende leven…. 
En tot slot: een warm woord van dank voor Karel, mijn vader, die mij ooit 
aanmoedigde om die professor (Kris Vissers) maar eens op te bellen om een 
afspraak te maken. ‘Dat zal hij waarschijnlijk best leuk vinden.’ Volgens mij 
heb je gelijk gekregen…… Ik heb veel van je geleerd en had graag nog langer 
van je willen leren. 
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Appendix 1 
Beck Depression Inventory (BDI-II) 
BDI-II VRAGENLIJST 
Aaron T. Beck, Dutch translation A.J. Willem van der Does. 
@2002, Harcourt Assessment B.V. Lisse 
Deze vragenlijst bestaat uit een aantal uitspraken die in groepen bij elkaar 
staan (1 t/m 21).  
Leest u iedere groep aandachtig door. Kies dan in elke groep de uitspraak 
die het best weer-geeft hoe u zich de AFGELOPEN 2 WEKEN, MET 
VANDAAG ERBIJ, gevoeld heeft.  
Omcirkel het cijfer dat vóór de door u gekozen uitspraak staat. Als in een 
groep meerdere uit-spraken even goed op u van toepassing zijn, omcirkel 
dan het cijfer van elk van deze uitspraken. 
LET ER OP DAT U ALLE UITSPRAKEN VAN EEN BEPAALDE GROEP LEEST, 
VOORDAT U UW KEUZE MAAKT. 
SOMBERHEID, VERDRIET 
1. 0. 
1. 
2. 
3. 
Ik voel me niet somber. 
Ik voel me een groot deel van de tijd somber. 
Ik ben de hele tijd somber. 
Ik ben zó somber of ongelukkig, dat ik het niet meer verdragen 
kan.  
 
PESSIMISME 
2. 0. 
1. 
2. 
3. 
Ik ben niet ontmoedigd over mijn toekomst. 
Ik ben meer ontmoedigd over mijn toekomst dan vroeger. 
Ik verwacht niet dat de dingen goed voor mij zullen uitpakken. 
Ik heb het gevoel dat de toekomst hopeloos is en dat het alleen 
maar erger zal worden.   
 
MISLUKKINGEN 
3. 0. 
1. 
2. 
3. 
Ik voel me geen mislukkeling. 
Ik heb te veel dingen laten mislukken. 
Als ik terugkijk, zie ik een hoop mislukkingen. 
Ik vind dat ik als persoon een totale mislukking ben.   
Speciale uitgave van het Universitair Medisch Centrum St. Radboud, te Nijmegen, speciaal vervaardigd 
na schriftelijke toestemming d.d. 5 december 2000, van de uitgever Harcourt te Lisse. 
 
Dit materiaal is auteursrechtelijk beschermd en kopiëren 
zonder schriftelijke toestemming van de uitgever is dan ook niet toegestaan. 
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VERLIES AAN PLEZIER 
4. 0. 
1. 
2. 
 
3. 
Ik beleef net zoveel plezier als altijd aan de dingen die ik leuk vind. 
Ik geniet niet meer zoveel van dingen als vroeger. 
Ik beleef heel weinig plezier aan de dingen die ik vroeger leuk 
vond. 
Ik beleef geen enkel plezier aan de dingen die ik vroeger leuk 
vond. 
 
SCHULDGEVOELENS 
5. 0. 
1. 
 
2. 
3. 
Ik voel me niet bijzonder schuldig. 
Ik voel me schuldig over veel dingen die ik heb gedaan of had 
moeten doen. 
Ik voel me meestal erg schuldig. 
Ik voel me de hele tijd schuldig. 
 
GEVOEL GESTRAFT TE WORDEN 
6. 0. 
1. 
2. 
3. 
Ik heb niet het gevoel gestraft te worden. 
Ik heb het gevoel dat ik misschien gestraft zal worden. 
Ik verwacht gestraft te worden. 
Ik heb het gevoel dat ik nu gestraft word. 
 
AFKEER VAN ZICHZELF 
7. 0. 
1. 
2. 
3. 
Ik voel me over mezelf net als altijd. 
Ik heb minder zelfvertrouwen. 
Ik ben teleurgesteld in mezelf. 
Ik heb een hekel aan mezelf. 
 
ZELFKRITIEK 
8. 0. 
1. 
2. 
3. 
Ik bekritiseer of verwijt mijzelf niet meer dan gewoonlijk. 
Ik ben meer kritisch op mezelf dan vroeger. 
Ik bekritiseer mezelf voor al mijn tekortkomingen. 
Ik verwijt mezelf al het slechte wat gebeurt. 
 
SUÏCIDALE GEDACHTEN OF WENSEN 
9. 0. 
1. 
 
2. 
3. 
Ik heb geen enkele gedachte aan zelfdoding. 
Ik heb gedachten aan zelfdoding, maar ik zou ze niet ten uitvoer 
brengen. 
Ik zou liever een eind aan mijn leven maken. 
Ik zou een eind aan mijn leven maken als ik de kans kreeg. 
 
HUILEN 
10. 0. 
1. 
2. 
3. 
Ik huil niet meer dan vroeger. 
Ik huil meer dan vroeger. 
Ik huil om elk klein ding. 
Ik wil graag huilen, maar ik kan het niet. 
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AGITATIE, ONRUST 
11. 0. 
1. 
2. 
3. 
Ik ben niet rustelozer of meer gespannen dan anders. 
Ik ben rustelozer of meer gespannen dan anders. 
Ik ben zo rusteloos of opgewonden dat ik moeilijk stil kan zitten. 
Ik ben zo rusteloos of opgewonden dat ik moet blijven bewegen of 
iets doen. 
 
VERLIES VAN INTERESSE 
12. 0. 
 
1. 
 
2. 
 
3. 
Mijn belangstelling voor andere mensen of activiteiten is niet 
verminderd. 
Ik heb nu minder belangstelling voor andere mensen of dingen 
dan vroeger. 
Ik heb mijn belangstelling voor andere mensen of dingen 
grotendeels verloren. 
Het is moeilijk nog ergens belangstelling voor op te brengen. 
 
BESLUITELOOSHEID 
13. 0. 
1. 
2. 
 
3. 
Ik neem beslissingen ongeveer even makkelijk als altijd. 
Ik vind het moeilijker om beslissingen te nemen dan gewoonlijk. 
Ik heb veel meer moeite met het nemen van beslissingen dan 
vroeger. 
Ik heb moeite met alle beslissingen. 
 
WAARDELOOSHEID 
14. 0. 
1. 
2. 
3. 
Ik heb niet het gevoel dat ik waardeloos ben. 
Ik zie mezelf niet meer zo waardevol en nuttig als vroeger. 
Vergeleken met anderen voel ik me meer waardeloos. 
Ik voel me volstrekt waardeloos. 
 
ENERGIEVERLIES 
15. 0. 
1. 
2. 
3. 
Ik heb nog evenveel energie als altijd. 
Ik heb minder energie dan vroeger. 
Ik heb niet voldoende energie om veel te doen. 
Ik heb niet genoeg energie om wat dan ook te doen. 
 
VERANDERING IN SLAAPPATROON 
16. 0. 
 
1a 
1b 
 
2a 
2b 
 
3a 
3b 
Mijn slaappatroon is niet veranderd. 
 
Ik slaap wat meer dan gewoonlijk. 
Ik slaap wat minder dan gewoonlijk. 
 
Ik slaap veel meer dan gewoonlijk. 
Ik slaap veel minder dan gewoonlijk. 
 
Ik slaap het grootste deel van de dag. 
Ik word 1-2 uur te vroeg wakker en kan niet meer inslapen. 
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PRIKKELBAARHEID 
17. 0. 
1. 
2. 
3. 
Ik ben niet meer geprikkeld dan anders. 
Ik heb meer prikkelbaar dan anders. 
Ik ben veel meer prikkelbaar dan anders. 
Ik ben de hele tijd prikkelbaar. 
 
VERANDERING VAN EETLUST 
18. 0. 
 
1a 
1b 
 
2a 
2b 
 
3a 
3b 
Mijn eetlust is niet veranderd. 
 
Mijn eetlust is wat kleiner dan gewoonlijk. 
Mijn eetlust is wat groter dan gewoonlijk. 
 
Mijn eetlust is veel kleiner dan gewoonlijk. 
Mijn eetlust is veel groter dan gewoonlijk. 
 
Ik heb helemaal geen eetlust. 
Ik verlang de hele tijd naar eten. 
 
CONCENTRATIEPROBLEMEN 
19. 0. 
1. 
2. 
3. 
Ik kan me net zo goed concentreren als altijd. 
Ik kan me niet zo goed concentreren als anders. 
Het is lastig om mijn gedachten ergens lang bij te houden. 
Ik kan me nergens op concentreren. 
 
MOEHEID 
20. 0. 
1. 
2. 
3. 
Ik ben niet meer moe of afgemat dan gewoonlijk. 
Ik word sneller moe of afgemat dan gewoonlijk. 
Ik ben te moe of afgemat voor veel dingen die ik vroeger wel deed. 
Ik ben te moe of afgemat voor de meeste dingen die ik vroeger wel 
deed. 
 
VERLIES VAN INTERESSE IN SEX 
21. 0. 
 
1. 
2. 
3. 
Ik heb de laatste tijd geen verandering gemerkt in mijn 
belangstelling voor sex. 
Ik heb minder belangstelling voor sex. 
Ik heb tegenwoordig veel minder belangstelling voor sex. 
Ik heb alle belangstelling voor sex verloren. 
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Appendix 2 
Hospital Anxiety and Depression Scale 
Het is bekend dat emoties bij de meeste ziektes een belangrijke rol spelen. 
Wanneer uw dokter weet hoe u zich voelt, zal deze beter in staat zijn u te 
helpen.  
Deze vragenlijst dient als hulpmiddel om te weten te komen hoe u zich voelt. 
Lees iedere vraag goed door en geef uw antwoord aan met een kruisje in het 
hokje dat het beste weergeeft hoe u zich gedurende de afgelopen week 
gevoeld heeft.  
Denk niet te lang na over uw antwoord. Het gaat bij al deze uitspraken om uw 
eigen indruk. Er bestaan geen foute antwoorden, elk antwoord is goed, zolang 
het maar uw eigen indruk weergeeft.  
 
Ik voel me gespannen:  
Γ Meestal  
Γ Vaak  
Γ Af en toe, soms  
Γ Helemaal niet  
 
Ik geniet nog steeds van de dingen 
waar ik vroeger van genoot:  
Γ Zeker zo veel  
Γ Wel wat minder  
Γ Duidelijk minder  
Γ Eigenlijk nauwelijks nog  
 
Ik heb een soort angstgevoel alsof er 
iets vreselijks zal gebeuren:  
Γ Jazeker, en vrij erg  
Γ Ja, maar niet zo erg  
Γ Een beetje, maar het hindert me niet  
Γ Helemaal niet  
 
Ik heb het gevoel dat alles moeizamer 
gaat:  
Γ Bijna altijd  
Γ Heel vaak  
Γ Soms  
Γ Helemaal niet  
 
Ik heb een soort angstig, gespannen 
gevoel in mijn buik:  
Γ Helemaal niet  
Γ Soms  
Γ Vrij vaak  
Γ Heel vaak  
 
Het interesseert me niet meer hoe ik 
er uit zie:  
Γ Inderdaad, helemaal niet meer  
Γ Niet meer zoveel als eigenlijk zou moeten  
Γ Het interesseert me wel, maar minder dan 
vroeger 
Γ Het interesseert me nog net zoveel als 
vroeger  
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Ik kan best lachen en de dingen van 
de vrolijke kant zien:  
Γ Net zoveel als vroeger  
Γ Nu wel wat minder  
Γ Duidelijk minder  
Γ Helemaal niet  
 
Ik maak me ongerust:  
Γ Heel erg vaak  
Γ Vaak  
Γ Af en toe, maar niet zo vaak  
Γ Heel soms  
 
Ik voel me opgewekt:  
Γ Helemaal niet  
Γ Heel af en toe  
Γ Soms  
Γ Meestal  
 
Ik kan best rustig zitten en me 
ontspannen:  
Γ Jazeker  
Γ Meestal  
Γ Af en toe  
Γ Helemaal niet  
Ik ben onrustig en voel dat ik iets te 
doen moet hebben:  
Γ Inderdaad, heel duidelijk  
Γ Duidelijk  
Γ Enigszins  
Γ Helemaal niet  
 
Ik verheug me van tevoren op dingen 
die komen gaan:  
Γ Net zoveel als vroeger  
Γ Een beetje minder dan vroeger  
Γ Veel minder dan vroeger  
Γ Bijna nooit  
 
Ik raak plotseling in paniek:  
Γ Inderdaad, zeer vaak  
Γ Tamelijk vaak  
Γ Soms  
Γ Helemaal nooit  
 
Ik kan van een goed boek genieten, of 
van een radio- of televisieprogramma:  
Γ Vaak  
Γ Tamelijk vaak  
Γ Af en toe  
Γ Heel zelden  
 
